Hill-Rom (HRC) 10-Q 31 Jul 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jun. 30, 2020	Jul. 29, 2020
Document And Entity Information Abstract
Document Type	10-Q
Title of 12(b) Security	Common Stock, without par value
Entity Shell Company	false
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2020
Document Transition Report	false
Entity File Number	1-6651
Entity Registrant Name	HILL-ROM HOLDINGS, INC.
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	35-1160484
Entity Address, Address Line One	130 E. Randolph St.
Entity Address, Address Line Two	Suite 1000
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60601
City Area Code	312
Local Phone Number	819-7200
Trading Symbol	HRC
Security Exchange Name	NYSE
Amendment Flag	false
Entity Central Index Key	0000047518
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		66,605,984
Entity Emerging Growth Company	false
Entity Small Business	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Product sales and service revenue	$ 685,800,000	$ 653,000,000	$ 1,947,100,000	$ 1,901,100,000
Rental revenue	81,700,000	73,800,000	228,600,000	223,400,000
Revenues	767,500,000	726,800,000	2,175,700,000	2,124,500,000
Total cost of net revenue (excludes acquisition-related intangible asset amortization)	323,100,000	332,300,000	946,600,000	971,300,000
Rental expenses	35,400,000	37,900,000	110,900,000	114,000,000
Cost of Revenue	358,500,000	370,200,000	1,057,500,000	1,085,300,000
Research and development expenses	34,400,000	34,100,000	100,300,000	103,900,000
Selling and administrative expenses	202,300,000	246,400,000	609,000,000
Selling and administrative expense, revised		217,100,000		613,300,000
Amortization of Intangible Assets	27,500,000	29,300,000	81,300,000	82,300,000
Special charges	9,500,000	6,200,000	26,100,000	17,700,000
Operating Profit	135,300,000	69,900,000	301,500,000	222,000,000
Interest expense	(17,300,000)	(23,100,000)	(55,800,000)	(66,200,000)
Gain (Loss) on Extinguishment of Debt	0	0	(15,600,000)	0
Investment income (expense) and other, net	2,200,000	(1,100,000)	(10,500,000)	200,000
Income Before Income Taxes	120,200,000	45,700,000	219,600,000	156,000,000
Income Before Income Taxes	120,200,000	45,700,000	219,600,000	156,000,000
Income tax expense	26,300,000	13,100,000	39,000,000	31,700,000
Net Income	$ 93,900,000	$ 32,600,000	$ 180,600,000	$ 124,300,000
Net Income Attributable to Common Shareholders per Common Share - Basic (usd per share)	$ 1.41	$ 0.49	$ 2.71	$ 1.86
Earnings Per Share, Diluted	$ 1.40	$ 0.48	$ 2.68	$ 1.84
Average Common Shares Outstanding - Basic (thousands) (Note 10) (in shares)	66,558	66,777	66,660	66,822
Average Common Shares Outstanding - Diluted (thousands) (Note 10) (in shares)	67,183	67,446	67,292	67,484

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
Net Income	$ 93.9	$ 32.6	$ 180.6	$ 124.3
Other Comprehensive (Loss) Income, net of tax (Note 7):
Derivative instruments designated as hedges	(6.7)	(9.4)	(32.4)	(15)
Foreign currency translation adjustment	17.1	4.1	8.6	(13.1)
Change in pension and postretirement defined benefit plans	1	0.4	(5.9)	1.3
Total Other Comprehensive Income (Loss), net of tax	11.4	(4.9)	(29.7)	(26.8)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ 105.3	$ 27.7	$ 150.9	$ 97.5

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2020	Sep. 30, 2019
Short-term borrowings	$ 250,100,000	$ 660,400,000
Long-term debt	1,782,600,000	1,783,100,000
Current Assets
Cash and cash equivalents	331,800,000	214,100,000
Restricted Cash, Current	0	419,700,000
Trade accounts receivable, net of allowances of $23.0 and $20.6 as of June 30, 2020 and September 30, 2019	646,200,000	653,300,000
Inventories, net of reserves	322,800,000	269,600,000
Other current assets	114,600,000	106,700,000
Total current assets	1,415,400,000	1,663,400,000
Property, plant and equipment	852,100,000	829,600,000
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	555,400,000	532,800,000
Property, Plant and Equipment, Net	296,700,000	296,800,000
Goodwill	1,816,900,000	1,800,900,000
Other intangible assets and software, net	988,500,000	1,033,500,000
Deferred Income Tax Assets, Net	33,500,000	33,100,000
Other assets	170,200,000	91,300,000
Assets	4,721,200,000	4,919,000,000
Current Liabilities
Trade accounts payable	221,700,000	197,600,000
Short-term borrowings	250,100,000	660,400,000
Accrued compensation	127,600,000	130,400,000
Accrued product warranties	30,500,000	29,700,000
Accrued rebates	39,800,000	47,700,000
Deferred Revenue	106,700,000	107,300,000
Other current liabilities	164,700,000	95,200,000
Total current liabilities	941,100,000	1,268,300,000
Long-term debt	1,782,600,000	1,783,100,000
Accrued pension and postretirement benefits	101,100,000	80,800,000
Deferred Income Tax Liabilities, Net	117,000,000	143,000,000
Other long-term liabilities	127,000,000	70,500,000
Total Liabilities	3,068,800,000	3,345,700,000
Commitments and Contingencies (Note 14)
SHAREHOLDERS' EQUITY
Common Stock, Value, Issued	4,400,000	4,400,000
Additional paid-in capital	654,400,000	637,400,000
Retained earnings	2,104,600,000	1,967,400,000
Accumulated other comprehensive income (loss)	(212,200,000)	(182,500,000)
Treasury stock, common shares at cost: 21,855,268 as of June 30, 2020 and 21,832,623 as of September 30, 2019	(898,800,000)	(853,400,000)
Total Shareholders’ Equity	1,652,400,000	1,573,300,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,652,400,000	1,573,300,000
Total Liabilities and Shareholders' Equity	4,721,200,000	4,919,000,000
Allowance for possible losses and discounts on trade receivables	$ 23	$ 20.6
Shares authorized	1,000,000
Common Stock, Shares Authorized	199,000,000
Common Stock, Shares, Issued	88,457,634
Common Stock, Shares, Outstanding	66,602,366	66,625,011
Treasury Stock, Common, Shares	21,855,268	21,832,623

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating Activities
Net Income (Loss) Attributable to Parent	$ 180,600,000	$ 124,300,000
Adjustments to reconcile net income to net cash, cash equivalents and restricted cash provided by operating activities:
Depreciation and Amortization of PP&E and Software	51,600,000	54,700,000
Acquisition-related intangible asset amortization	81,300,000	82,300,000
Amortization of Debt Issuance Costs and Discounts	3,000,000	4,800,000
Gain (Loss) on Extinguishment of Debt	15,600,000	0
Benefit for deferred income taxes	(14,100,000)	(12,200,000)
Loss on disposal of property, equipment, intangible assets, and impairments	1,500,000	3,300,000
Stock compensation	27,200,000	26,900,000
Other Operating Activities, Cash Flow Statement	16,000,000	(2,900,000)
Change in working capital excluding cash, current debt, acquisitions and dispositions:
Trade accounts receivable	12,300,000	15,300,000
Inventories	(60,200,000)	(4,900,000)
Other current assets	(10,400,000)	(3,500,000)
Trade accounts payable	16,500,000	(9,000,000)
Accrued expenses and other liabilities	(8,100,000)	14,300,000
Increase (Decrease) in Accounts Receivable	(12,300,000)	(15,300,000)
Increase (Decrease) in Inventories	60,200,000	4,900,000
Increase (Decrease) in Other Operating Assets	10,400,000	3,500,000
Increase (Decrease) in Accounts Payable, Trade	16,500,000	(9,000,000)
Accrued expenses and other liabilities	(8,100,000)	14,300,000
Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net	(2,000,000)	(7,700,000)
Net cash, cash equivalents and restricted cash provided by operating activities	314,800,000	301,100,000
Investing Activities
Purchases of property, plant, equipment and software	(72,000,000)	50,900,000
Proceeds on sale of property and equipment	1,600,000	2,500,000
Payments to Acquire Businesses, Gross	(20,600,000)	(175,800,000)
Payments to Acquire Intangible Assets	0	(17,100,000)
Payments to Acquire Investments	0	(26,600,000)
Other investing activities	600,000	0
Financing Activities
Payment of long-term debt	37,600,000	(100,000)
Borrowings on Revolving Credit Facility	190,000,000	(330,000,000)
Payments on Revolving Credit Facility	155,000,000	(230,000,000)
Borrowings on Securitization Facility	17,700,000	4,900,000
Payments on Securitization Facility	(17,700,000)	5,500,000
Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement	32,600,000	46,000,000
Payments on Note Securitization Facility	(21,200,000)	51,300,000
Payment for Debt Extinguishment or Debt Prepayment Cost	(12,200,000)	0
Repayments of Senior Debt	(425,000,000)	0
Cash dividends	(43,300,000)	(41,400,000)
Proceeds on exercise of stock options	8,500,000	9,200,000
Payment, Tax Withholding, Share-based Payment Arrangement	(16,400,000)	(4,200,000)
Payments for Repurchase of Common Stock	(54,100,000)	75,000,000
Proceeds from (Payments for) Other Financing Activities	6,000,000	5,500,000
Net cash, cash equivalents and restricted cash used in financing activities	(527,700,000)	(11,900,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,300,000	(1,700,000)
Net Cash Flows	(302,000,000)	19,600,000
Cash, Cash Equivalents and Restricted Cash:
Cash and cash equivalents	331,800,000	202,600,000
At beginning of period	214,100,000	183,000,000
At end of period	331,800,000	202,600,000
Capital Expenditures Incurred but Not yet Paid	1,800,000	2,300,000
Restricted Stock or Unit Expense	29,600,000	10,400,000
Equity Method Investment, Realized Gain (Loss) on Disposal	2,100,000
Net Income (Loss) Attributable to Parent	180,600,000	124,300,000
Net Cash Provided by (Used in) Investing Activities	(90,400,000)	(267,900,000)
Treasury Stock [Member]
Financing Activities
Payment, Tax Withholding, Share-based Payment Arrangement	$ 16,400,000	$ (4,200,000)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity (unaudited) Statement - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2018		88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Sep. 30, 2018	$ 1,616,200,000	$ 4,400,000	$ 602,900,000	$ 1,876,200,000	$ (113,000,000)	$ (754,300,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative Effect on Retained Earnings, Net of Tax | Accounting Standards Update 2014-09 [Member]	(4,900,000)			(4,900,000)
Cumulative Effect on Retained Earnings, Net of Tax | Accounting Standards Update 2016-16 [Member]	(5,600,000)			(5,600,000)
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				5,400,000	(5,400,000)
Net Income	124,300,000
Net Income (Loss) Attributable to Parent	124,300,000
Other Comprehensive Income (Loss), Net of Tax	(26,800,000)				(26,800,000)
Dividends	(41,400,000)		300,000	(41,700,000)
Payment, Tax Withholding, Share-based Payment Arrangement	(4,200,000)					(4,200,000)
Payments for Repurchase of Common Stock	(75,000,000)					(75,000,000)
Share-based Compensation on Equity-Classified Awards	26,700,000		26,700,000
Stock Issued During Period, Value, Stock Options Exercised	(9,200,000)		(2,100,000)			(7,100,000)
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition			(4,900,000)
Stock Issued During Period, Value, Restricted Stock Award, Gross	0					4,900,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	6,200,000		3,900,000			2,300,000
Cumulative Effect on Retained Earnings, Tax | Accounting Standards Update 2014-09 [Member]				4,800,000
Cumulative Effect on Retained Earnings, Tax | Accounting Standards Update 2016-16 [Member]				200,000
Payments for Repurchase of Common Stock	$ (75,000,000)
Other Comprehensive Income (Loss), Tax					4,000,000
Common Stock, Dividends, Per Share, Cash Paid	$ 0.62
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2019		88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	$ 1,624,700,000	$ 4,400,000	631,000,000	1,953,700,000	(145,200,000)	(819,200,000)
Common Stock, Shares, Outstanding, Beginning Balance at Mar. 31, 2019		88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2019	1,598,800,000	$ 4,400,000	619,900,000	1,935,200,000	(140,300,000)	(820,400,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	32,600,000
Net Income (Loss) Attributable to Parent	32,600,000
Other Comprehensive Income (Loss), Net of Tax	(4,900,000)				(4,900,000)
Dividends	(14,000,000)		100,000	14,100,000
Payment, Tax Withholding, Share-based Payment Arrangement	(200,000)					200,000
Share-based Compensation on Equity-Classified Awards	9,800,000		9,800,000
Stock Issued During Period, Value, Stock Options Exercised	(600,000)		(100,000)			(500,000)
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition			(200,000)
Stock Issued During Period, Value, Restricted Stock Award, Gross	0					200,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 2,000,000		1,300,000			700,000
Other Comprehensive Income (Loss), Tax					(2,500,000)
Common Stock, Dividends, Per Share, Cash Paid	$ 0.21
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2019		88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	$ 1,624,700,000	$ 4,400,000	631,000,000	1,953,700,000	(145,200,000)	(819,200,000)
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2019	66,625,011	88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Sep. 30, 2019	$ 1,573,300,000	$ 4,400,000	637,400,000	1,967,400,000	(182,500,000)	(853,400,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative Effect on Retained Earnings, Net of Tax | Accounting Standards Update 2014-09 [Member]	300,000			300,000
Net Income	180,600,000
Net Income (Loss) Attributable to Parent	180,600,000
Other Comprehensive Income (Loss), Net of Tax	(29,700,000)				(29,700,000)
Dividends	(43,300,000)		400,000	(43,700,000)
Payment, Tax Withholding, Share-based Payment Arrangement	(16,400,000)					16,400,000
Payments for Repurchase of Common Stock	(54,100,000)					(54,100,000)
Share-based Compensation on Equity-Classified Awards	26,400,000		26,400,000
Stock Issued During Period, Value, Stock Options Exercised	(8,500,000)		(2,900,000)			(5,600,000)
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition			(16,900,000)
Stock Issued During Period, Value, Restricted Stock Award, Gross	0					16,900,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	6,800,000		4,200,000			2,600,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		0
Cumulative Effect on Retained Earnings, Tax | Accounting Standards Update 2014-09 [Member]				100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		0
Payments for Repurchase of Common Stock	$ 54,100,000
Other Comprehensive Income (Loss), Tax					11,400,000
Common Stock, Dividends, Per Share, Cash Paid	$ 0.65
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2020	66,602,366	88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020	$ 1,652,400,000	$ 4,400,000	654,400,000	2,104,600,000	(212,200,000)	(898,800,000)
Common Stock, Shares, Outstanding, Beginning Balance at Mar. 31, 2020		88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2020	1,548,900,000	$ 4,400,000	644,400,000	2,025,200,000	(223,600,000)	(901,500,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative Effect on Retained Earnings, Net of Tax | Accounting Standards Update 2014-09 [Member]	300,000			300,000
Net Income	93,900,000
Net Income (Loss) Attributable to Parent	93,900,000
Other Comprehensive Income (Loss), Net of Tax	11,400,000				11,400,000
Dividends	14,600,000		200,000	14,800,000
Payment, Tax Withholding, Share-based Payment Arrangement	600,000					600,000
Share-based Compensation on Equity-Classified Awards	7,900,000		7,900,000
Stock Issued During Period, Value, Stock Options Exercised	(2,800,000)		(1,200,000)			(1,600,000)
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition			(800,000)
Stock Issued During Period, Value, Restricted Stock Award, Gross	(100,000)					700,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 2,500,000		1,500,000			1,000,000
Cumulative Effect on Retained Earnings, Tax | Accounting Standards Update 2014-09 [Member]				100,000
Other Comprehensive Income (Loss), Tax					(1,600,000)
Common Stock, Dividends, Per Share, Cash Paid	$ 0.22
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2020	66,602,366	88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020	$ 1,652,400,000	$ 4,400,000	$ 654,400,000	$ 2,104,600,000	$ (212,200,000)	$ (898,800,000)

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Nature of Operations Hill-Rom Holdings, Inc. (the “Company,” “Hillrom,” “we,” “us,” or “our”) was incorporated on August 7, 1969 in the State of Indiana and is headquartered in Chicago, Illinois. We are a global medical technology leader whose approximately 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, our innovations touch over 7 million patients each day. Our products and services help enable earlier diagnosis and treatment, optimize surgical efficiency, and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. We make these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory health devices, advanced equipment for the surgical space and more, delivering actionable, real-time insights at the point of care. Basis of Presentation and Principles of Consolidation The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in Hillrom’s latest fiscal 2019 Form 10-K as filed with the SEC. The September 30, 2019 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements but does not include all disclosures required by accounting principles generally accepted in the United States. In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments necessary to state fairly the financial position, results of operations, and cash flows for the interim periods presented. Quarterly results are not necessarily indicative of annual results. The Condensed Consolidated Financial Statements include the accounts of Hillrom and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. The Company makes a number of significant estimates, assumptions, and judgments in the preparation of its financial statements. Additionally, the Company measures and classifies fair value measurements in accordance with the level hierarchy in conformity with accounting principles generally accepted in the United States (“GAAP”). As of June 30, 2020, the Company's significant accounting policies and estimates and valuation techniques used to measure fair value have not changed from September 30, 2019. See Note 1. Summary of Significant Accounting Policies within the 2019 Form 10-K for the fiscal year ended September 30, 2019 for further information. Prior Period Reclassification Beginning in fiscal year 2020, we are presenting Acquisition-related intangible asset amortization as a separate line item on our Condensed Consolidated Statements of Income for all periods presented. Acquisition-related intangible asset amortization was previously included in Selling and administrative expenses. Additionally, we will no longer present Gross Profit as a subtotal on our Statements of Income. The following table presents Acquisition-related intangible asset amortization and Selling and administrative expenses, excluding the Acquisition-related intangible asset amortization, for the years ended September 30, 2019, 2018 and 2017, and for each quarterly period of fiscal 2019. Quarter Ended Year Ended December 31, March 31, June 30, September 30, September 30, September 30, September 30, Selling and administrative expense, previously reported $ 218.0 $ 231.2 $ 246.4 $ 245.4 $ 941.0 $ 891.6 $ 874.5 Less, Acquisition-related intangible asset amortization 25.7 27.3 29.3 40.1 122.4 106.9 108.4 Selling and administrative expense, currently reported $ 192.3 $ 203.9 $ 217.1 $ 205.3 $ 818.6 $ 784.7 $ 766.1 Goodwill and Indefinite-Lived Intangible Assets Testing for goodwill and indefinite-lived intangible asset impairment is performed annually, or on an interim basis upon the occurrence of a triggering event or change in circumstances that would more likely than not reduce the fair value of a reporting unit or indefinite-lived intangible asset below its carrying amount. The annual evaluations of goodwill and the indefinite-lived intangible asset for impairment were performed as of April 30, 2020 and did not result in any impairment. For the Surgical Solutions segment, we continue to expect near-term lower demand for operating room infrastructure due to project delays as customers are currently focusing on the demands of the pandemic. Slower recovery resulting from extended project delays, an increase in discount rates, unfavorable changes in earnings multiples, or a decline in future cash flow projections, among other factors, may cause a change in circumstances indicating that the carrying value of our goodwill may not be recoverable. If future financial assumptions significantly differ from those evaluated in the assessment noted above due to duration or magnitude of the impact of COVID-19, we can provide no assurance that a future goodwill impairment charge would not be incurred. Government Programs Related to COVID-19 On March 25, 2020, the U.S. government approved the Coronavirus Aid, Relief and Economic Security (“CARES”) Act to provide economic stimulus to address the impact of the pandemic. The governments in certain other non-U.S. countries have also approved legislation in their jurisdictions to address the impact of the pandemic. We have evaluated our eligibility and assessed the conditions and requirements of participation in many programs. For the programs in which we have elected to participate, we recognized $2.4 million in government grants and cost abatements associated with state aid within the Condensed Consolidated Statement of Income for the three and nine months ended June 30, 2020. In addition, we have deferred the payment of the employer share of the U.S. Federal Insurance Contributions Act (“FICA”) tax payments totaling $6.9 million in accordance with the CARES Act within the Condensed Consolidated Balance Sheet as of June 30, 2020. We continue to evaluate what impact, if any, the CARES Act, or any similar legislation in other non-U.S. jurisdictions, may have on our results of operations. Recently Adopted Accounting Standards In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) and subsequently issued related amendments, collectively referred to as “ASC 842”. The objective of this guidance is to increase transparency and comparability among organizations through recognizing leased assets, called right-of-use assets (“ROU”), and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. As a lessee, the new standard requires us to recognize both the ROU assets and lease liabilities in the balance sheet for most leases, whereas under previous GAAP only finance lease liabilities (referred to as capital leases) were recognized in the balance sheet. In addition, for both lessees and lessors, the definition of a lease has been revised, which may result in changes to the classification of an arrangement as a lease. Under the new standard, an arrangement that conveys the right to control the use of an identified asset by obtaining substantially all of its economic benefits and directing how it is used is a lease, whereas the previous definition focused on the ability to control the use of the asset or to obtain its output. Quantitative and qualitative disclosures related to the amount, timing and judgments of an entity’s accounting for leases and the related cash flows are expanded under the new standard. Disclosure requirements apply to both lessees and lessors, whereas previous disclosures related only to lessees. The recognition, measurement, and presentation of revenues, expenses, and cash flows arising from a lease have not significantly changed from previous GAAP. We adopted ASC 842 effective October 1, 2019 using the optional transition method approach. We elected the package of practical expedients, which applies to both lessees and lessors, to (1) not reassess whether existing contracts contain leases, (2) carryforward the existing lease classification, and (3) not reassess initial direct costs associated with existing leases. As a lessee, the adoption of the guidance on October 1, 2019 resulted in the recognition of ROU assets of $82.5 million and lease liabilities of $85.8 million, which all related to operating leases. The ROU assets were lower than the lease liabilities due to the derecognition of deferred rent balances of $3.3 million. As a lessor, there was no impact as a result of the adoption. We did not recognize any adjustment to the comparative period presented in the financial statements in accordance with our adoption method. The guidance did not have a material impact on our Condensed Consolidated Statements of Income. See Note 7. Leases for additional information on the impacts of ASC 842. In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This standard eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. ASU 2017-04 is effective for our first quarter of fiscal 2021 and requires a prospective transition method. Early adoption is permitted. We early adopted this standard in the first quarter of fiscal 2020 and the guidance did not have a material impact on our Condensed Consolidated Financial Statements. In October 2018, the FASB issued ASU 2018-16, Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes . The purpose of the standard is to allow the use of the OIS rate based on the SOFR for hedge accounting purposes, which allows entities to designate changes in the fair values of fixed-rate financial assets or liabilities attributable to the OIS rate as the hedged risk. The amendment recognizes the OIS rate based on the SOFR as likely London Interbank Offered Rate (“LIBOR”) replacements and supports the marketplace transition by adding the new reference rate as a benchmark rate. We adopted this standard in the first quarter of fiscal 2020. The adoption of this ASU did not impact our financial statements as we have not yet utilized the OIS rate based on the SOFR for borrowings under our lending arrangements or as a benchmark rate for hedge accounting purposes. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The purpose of the standard is to provide guidance for the effects of the marketplace transition from LIBOR to a new reference rate as a benchmark rate. ASU 2020-04 is optional and is effective for a limited period of time from March 12, 2020 through December 31, 2022. We will continue to monitor, assess, and plan for the phase out of LIBOR. Recently Issued Accounting Standards In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments and subsequently issued related amendments, collectively referred to as “Topic 326”. Topic 326 requires entities to measure credit losses for financial assets measured at amortized cost based on expected losses rather than incurred losses. For available-for-sale debt securities with unrealized losses, entities will recognize credit losses through an allowance for credit losses. Topic 326 is effective for our first quarter of fiscal 2021 and requires a prospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement . The purpose of the standard is to improve the overall usefulness of fair value disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-13 is effective for our first quarter of fiscal 2021 and requires the application of the prospective method of transition (for only the most recent interim or annual period presented in the initial fiscal year of adoption) to the new disclosure requirements for (1) changes in unrealized gains and losses included in other comprehensive income and (2) the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU 2018-13 also requires prospective application to any modifications to disclosures made because of the change to the requirements for the narrative description of measurement uncertainty. The effects of all other amendments made by ASU 2018-13 must be applied retrospectively to all periods presented. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits – Defined Benefit Plans – General (Topic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans. The purpose of the standard is to improve the overall usefulness of defined benefit pension and other postretirement plan disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-14 is effective for our annual disclosures for fiscal 2021 and requires a retrospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-15, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract . This update aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement to be consistent with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). ASU 2018-15 is effective for our first quarter of fiscal 2021 and allows a retrospective or a prospective transition method to all implementation costs incurred after the date of adoption. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 . The purpose of the standard is to (1) clarify that transactions between participants in a collaborative agreement should be accounted for under Topic 606 and (2) add unit-of-account guidance in Topic 808 to align with Topic 606. ASU 2018-18 is effective for our first quarter of fiscal 2021 and must be applied retrospectively to the first quarter of fiscal 2020. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The purpose of the standard is to remove certain exceptions to the general principles of Topic 740: Income Taxes in order to reduce the cost and complexity of its application and to maintain or improve the usefulness of the information provided to users of financial statements. ASU 2019-12 is effective for our first quarter of fiscal 2022 and will be applied either retrospectively or prospectively depending on the specific Topic 740 exception affected. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. Except as noted above, there are no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1. Summary of Significant Accounting Policies of our Consolidated Financial Statements in our 2019 Form 10-K.
Nature of Operations	Hill-Rom Holdings, Inc. (the “Company,” “Hillrom,” “we,” “us,” or “our”) was incorporated on August 7, 1969 in the State of Indiana and is headquartered in Chicago, Illinois. We are a global medical technology leader whose approximately 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, our innovations touch over 7 million patients each day. Our products and services help enable earlier diagnosis and treatment, optimize surgical efficiency, and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. We make these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory health devices, advanced equipment for the surgical space and more, delivering actionable, real-time insights at the point of care.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Jun. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue from Contracts with Customers As of June 30, 2020, the Company's significant accounting policies for recognizing revenue have not changed from September 30, 2019. See Note 1. Summary of Significant Accounting Policies and Note 2. Revenue Recognition within our 2019 Form 10-K for the fiscal year ended September 30, 2019 for further information. Disaggregation of Revenue The Company disaggregates revenue recognized from contracts with customers by geography and reportable segments consistent with the way in which management operates and views the business. See Note 14. Segment Reporting for the presentation of the Company's revenue disaggregation. Contract Balances The nature of our products and services does not give rise to contract assets as we typically do not have instances where a right to payment for goods and services already transferred to a customer exists that is conditional on something other than the passage of time. The following summarizes contract liability activity for the nine months ended June 30, 2020. The contract liability balance represents the transaction price allocated to the remaining performance obligations. Contract Liabilities Balance as of September 30, 2019 125.8 Deferred revenue acquired 2.7 New revenue deferrals 220.4 Revenue recognized upon satisfaction of performance obligations (214.1) Balance as of June 30, 2020 $ 134.8 These contract liabilities are recorded in Deferred revenue and Other long-term liabilities. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within 12 to 24 months.

Supplementary Balance Sheet Inf

Supplementary Balance Sheet Information	9 Months Ended
	Jun. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Supplementary Balance Sheet Information	Supplementary Financial Statement Information June 30, September 30, 2019 Inventories, net of reserves: Finished products $ 143.1 $ 120.5 Work in process 49.6 42.4 Raw materials 130.1 106.7 Total inventories, net of reserves $ 322.8 $ 269.6 Accumulated amortization of software and other intangible assets $ 635.7 $ 597.0 Investments included in Other assets $ 47.6 $ 51.1 Investments In the first quarter of fiscal 2019, we acquired $26.6 million of non-marketable equity securities that are valued at cost. During the nine months ended June 30, 2020, we sold an equity investment with a carrying value of $3.1 million and recognized a loss of $0.3 million and recognized an impairment loss of $1.7 million on a cost method investment. These losses were recorded as a component of Investment income (expense) and other, net. Supplemental Cash Flow Information Nine Months Ended June 30 2020 2019 Non-cash investing activities: Change in capital expenditures not paid $ 1.8 $ 2.3 Sale of equity method investment 2.1 — Total non-cash investing activities: $ 3.9 $ 2.3 Non-cash financing activities: Distribution of shares issued under stock-based compensation plans $ 29.6 $ 10.4

Acquisitions

Acquisitions	9 Months Ended
	Jun. 30, 2020
Business Combinations [Abstract]
Acquisitions	Business Combinations Acquisitions Connecta Soft, S.A. de C.V. On May 18, 2020, we acquired the multiplatform medical device integration and connectivity software programs, products, and solutions of Connecta Soft, S.A. de C.V. (“Connecta”), a clinical communications software company based in Mexico, for total aggregate consideration of $7.7 million, comprised of $7.5 million cash and $0.2 million of contingent consideration measured at fair value as of the acquisition date. Contingent consideration is payable up to $4.0 million based upon the achievement of certain commercial milestones over the next 3.5 years. The purchase price is subject to certain post-closing adjustments. The results of Connecta are included in the Front Line Care segment since the date of acquisition. The impact to reported revenue and net income for the three and nine months ended June 30, 2020 was not significant. The following table summarizes the preliminary estimate of the fair value of assets acquired at the date of the Connecta acquisition. The fair value of assets acquired is still considered to be preliminary, however we do not expect further adjustments to be significant. Amount Goodwill $ 4.8 Developed technology 2.9 Total purchase price $ 7.7 Goodwill in connection with the Connecta acquisition of $4.8 million was recognized at the acquisition date related to the excess of the purchase price over the estimated fair value of the assets acquired, reflecting the value associated with advancing connected care in Mexico as well as creating lower cost opportunities to expand to other emerging markets. The goodwill was allocated entirely to our Front Line Care segment and is deductible for tax purposes in the United States. The estimated useful life of the acquired developed technology is 10 years. For the three and nine months ended June 30, 2020, we recognized $0.3 million of acquisition and integration costs associated with this transaction in Selling and administrative expenses. Excel Medical Electronics On January 10, 2020, we acquired all of the outstanding equity interest of Excel Medical Electronics (“Excel Medical”), a clinical communications software company located in the United States, for total aggregate consideration of $19.2 million, comprised of $13.1 million cash and $6.1 million of contingent consideration measured at fair value as of the acquisition date. The purchase price is subject to certain post-closing adjustments. Contingent consideration is comprised of $1.6 million, which was withheld at the close of the transaction and is payable upon completion of a supply contract modification, and estimated consideration measured at a fair value of $4.5 million, which is payable of up to $15.0 million based upon the achievement of certain commercial milestones over the next two years. The results of Excel Medical are included in the Patient Support Systems segment since the date of acquisition. The impact to reported revenue and net income for the three and nine months ended June 30, 2020 was not significant. The following table summarizes the preliminary estimate of the fair value of assets acquired and liabilities assumed at the date of the Excel Medical acquisition. The fair values of assets acquired and liabilities assumed are still considered to be preliminary, however we do not expect further adjustments to be significant. Amount Trade accounts receivable $ 0.6 Inventories 0.9 Other current assets 0.1 Property, plant and equipment 0.1 Goodwill 9.8 Developed technology 10.9 Deferred revenue (2.7) Other current liabilities (0.5) Total purchase price, net of cash acquired $ 19.2 Goodwill in connection with the Excel Medical acquisition of $9.8 million was recognized at the acquisition date related to the excess of the purchase price over the estimated fair value of the assets acquired and the liabilities assumed, reflecting the value associated with enhancing synergies, accelerating our leadership in care communications platform, and advancing our digital and mobile communications platform and capabilities. The goodwill was allocated entirely to our Patient Support Systems segment and is deductible for tax purposes in the United States. The estimated useful life of the acquired intangible assets is 5 years for developed technology. For the three and nine months ended June 30, 2020, we recognized $0.6 million and $1.4 million of acquisition and integration costs, including $0.5 million and $0.7 million related to contingent consideration, associated with this transaction in Selling and administrative expenses. Breathe Technologies, Inc. On September 3, 2019, we acquired all of the outstanding equity interests of Breathe Technologies, Inc. (“Breathe”), a developer and manufacturer of a patented wearable, non-invasive ventilation technology that supports improved patient mobility, for total aggregate cash consideration of $127.6 million. The results of Breathe are included in the Front Line Care segment since the date of acquisition. The following table summarizes the preliminary estimate of the fair value of assets acquired and liabilities assumed at the date of the Breathe acquisition. The fair value of assets acquired and liabilities assumed are still considered to be preliminary, however we do not expect further adjustments to be significant. Amount Trade accounts receivable $ 0.3 Inventories 6.3 Other current assets 0.1 Property, plant and equipment 2.1 Goodwill 60.2 Trade name 4.0 Customer relationships 0.4 Developed technology 56.0 Other assets 0.2 Trade accounts payable (0.5) Other current liabilities (1.6) Deferred income taxes 0.9 Other long-term liabilities (0.8) Total purchase price, net of cash acquired $ 127.6 Goodwill in connection with the Breathe acquisition of $60.2 million was recognized at the acquisition date related to the excess of the purchase price over the estimated fair value of the assets acquired and the liabilities assumed, reflecting the value associated with enhancing synergies and accelerating our leadership in respiratory health products. The goodwill was allocated entirely to our Front Line Care segment and is not deductible for tax purposes in the United States. The estimated useful lives of the acquired intangible assets are 2 years for trade name, 8 years for customer relationships and 11 years for developed technology. For the three and nine months ended June 30, 2020, we recognized $0.5 million and $2.0 million of acquisition and integration costs in Selling and administrative expenses and $0.4 million and $2.7 million in Special charges related to this acquisition. Voalte, Inc. On April 1, 2019, we acquired all of the outstanding equity interests of Voalte, Inc. (“Voalte”), a clinical communications software company located in the United States, for total aggregate consideration of $181.0 million, comprised of $175.8 million cash and $5.2 million of contingent consideration measured at fair value as of the acquisition date. Contingent consideration was payable up to $15.0 million based upon achievement of certain commercial milestones by March 31, 2020. In the first quarter of fiscal 2020, we reduced the contingent consideration accrual by $8.4 million as the commercial milestones were not expected to be achieved, which was recorded as a component of Selling and administrative expenses. No contingent consideration was paid as the milestones were not achieved. The results of Voalte are included in the Patient Support Systems segment since the date of acquisition. The following table summarizes the fair value of assets acquired and liabilities assumed at the date of the Voalte acquisition. Amount Trade accounts receivable $ 5.8 Inventories 0.1 Other current assets 2.7 Property, plant and equipment 0.2 Goodwill 98.5 Non-competition agreements 2.7 Trade name 13.5 Customer relationships 29.0 Developed technology 55.0 Trade accounts payable (1.7) Deferred revenue (10.7) Other current liabilities (4.3) Deferred income taxes (9.8) Total purchase price, net of cash acquired $ 181.0 Goodwill in connection with the Voalte acquisition of $98.5 million was recognized at the acquisition date related to the excess of the purchase price over the estimated fair value of the assets acquired and the liabilities assumed, reflecting the value associated with enhancing synergies, accelerating our leadership in care communications platform and advancing our digital and mobile communications platform and capabilities. The goodwill was allocated entirely to our Patient Support Systems segment and is not deductible for tax purposes in the United States. The estimated useful lives of the acquired intangible assets are 5 years for non-competition agreements and between 8 and 10 years for trade name, customer relationships and developed technology. Videomed On July 21, 2020, we closed on the acquisition of Videomed S.r.l. (“Videomed”), a developer of integrated video solutions in operating rooms, for cash consideration of $9.4 million, subject to certain post-closing adjustments. Additionally, contingent consideration is payable up to $3.7 million based upon the achievement of certain commercial milestones. The results of Videomed will be included in the Surgical Solutions segment from the date of acquisition. It is not practical to disclose the preliminary purchase price allocation for this transaction given the short period of time between the acquisition date and the filing of this report . Asset Acquisition On October 1, 2018, we acquired the right to use patented technology and certain related assets from a supplier to our Front Line Care segment. We paid $17.1 million of cash and committed to guaranteed minimum future royalty payments of $22.0 million, which are presented in Other intangible assets and software, net and are being amortized over the 7-year term of the agreement. Disposition On August 2, 2019, we completed a disposition to sell certain of our surgical consumable products and related assets for a purchase price of $166.6 million, which is net of cash and working capital adjustments. In fiscal 2019, we recorded pre-tax loss on this disposition of $15.9 million, including transaction costs of $4.0 million, in Investment income (expense) and other, net. During the three and nine months ended June 30, 2020, we recorded additional losses of $3.9 million and $4.2 million related to this transaction primarily due to income taxes. See Note 11. Income Taxes for further information. This disposition did not have a significant effect on our operations or financial results, and, therefore, has not been reported as a discontinued operation.

Financing Agreements

Financing Agreements	9 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements Short-Term Borrowings Securitization Facilities In April 2020, we renewed our 364-day accounts receivable securitization program (the “Securitization Facility”) with certain financial institutions for borrowings up to $110.0 million. We also renewed our additional 364-day facility for borrowings up to $90.0 million (the “Note Securitization Facility”) in April 2020. The terms and conditions of the renewed April 2020 facilities are substantially similar to the May 2019 facilities. Under the terms of each the Securitization Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount of permissible borrowings outstanding is determined based on the amount of qualifying accounts receivable at any point in time. Borrowings outstanding under the Securitization Facility and Note Securitization Facility bear interest at LIBOR plus the applicable margin of 0.8% and 0.9% and are included as a component of Short-term borrowings, while the accounts receivable securing these obligations remain as a component of Trade accounts receivable, net of allowances. Long-Term Debt As of June 30, 2020, there were $115.0 million outstanding borrowings on the Revolving Credit Facility and available borrowing capacity was $1,077.8 million after giving effect to the $7.2 million of outstanding standby letters of credit. As of September 30, 2019, there were $80.0 million outstanding borrowings on the Revolving Credit Facility, and available borrowing capacity was $1,112.8 million after giving effect to $7.2 million of outstanding standby letters of credit. Long-Term Debt Redemption In September 2019, we issued senior unsecured notes of $425.0 million maturing September 2027 that bear interest at a fixed rate of 4.375% annually and capitalized debt issuance costs of $6.3 million. On October 7, 2019, we used the net proceeds from the offering of these notes, together with funds borrowed from the Revolving Credit Facility maturing in August 2024, to redeem all of our previously outstanding senior unsecured 5.75% notes due September 2023 and to pay the prepayment premium of $12.2 million. We recorded a loss on extinguishment of debt of $15.6 million, which was comprised of the $12.2 million prepayment premium and $3.4 million of debt issuance costs previously capitalized. See Note 6. Financing Agreements within the 2019 Form 10-K for the fiscal year ended September 30, 2019 for further information. Fair Value The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our variable rate short-term debt instruments, our variable rate senior secured Term Loan A facility maturing in August 2024 and our variable rate Revolving Credit Facility approximate fair value. The estimated fair values of our long-term debt instruments are described in the table below: June 30, September 30, 2019 Senior unsecured 5.00% notes due on February 14, 2025 $ 310.5 $ 312.4 Senior unsecured 4.375% notes due on September 15, 2027 435.4 435.4 Unsecured debentures 47.0 48.1 Total $ 792.9 $ 795.9 The estimated fair values of our long-term unsecured debentures were based on observable inputs such as quoted prices in markets that are not active. The estimated fair values of the Senior Notes were based on quoted prices for similar liabilities. These fair value measurements were classified as Level 2. Debt Covenants As of June 30, 2020, we were in compliance with all debt covenants under our financing agreements.

Derivatives

Derivatives	9 Months Ended
	Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	Derivative Instruments and Hedging Activity We are exposed to various market risks, including fluctuations in interest rates and variability in foreign currency exchange rates. We have established policies, procedures, and internal processes governing our management of market risks and the use of financial instruments to manage our exposure to such risks. We employ cash flow hedges, net investment hedges, and other derivative instruments not designated for hedge accounting to manage these risks. Cash Flow Hedges To manage our exposure to market risk from fluctuations in interest rates, we enter into interest rate swaps that are designated as cash flow hedges. As of June 30, 2020, we had interest rate swap agreements with an aggregate notional amount of $750.0 million to hedge the variability of cash flows through August 2024 associated with a portion of the variable interest rate payments on outstanding borrowings under our Senior Credit Agreement. As of September 30, 2019, we had interest rate swap agreements, with an aggregate notional amount of $750.0 million to hedge the variability of cash flows associated with a portion of the variable interest rate payments on outstanding borrowings under our Senior Credit Agreement through September 2021. We are subject to variability in foreign currency exchange rates due to our international operations. We enter into currency exchange contracts that are designated as cash flow hedges to manage our exposure arising from fluctuating exchange rates related to specific and projected transactions. We operate this program pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. The sensitivity of earnings and cash flows to variability in exchange rates is assessed by applying an appropriate range of potential rate fluctuations to our assets, obligations, and projected results of operations denominated in foreign currencies. Our currency risk consists primarily of foreign currency denominated firm commitments and projected foreign currency denominated intercompany and third-party transactions. As of June 30, 2020, the notional amount of outstanding currency exchange contracts was $13.6 million. As of September 30, 2019, the notional amount of outstanding currency exchange contracts was $6.7 million. The maximum length of time over which we hedge transaction exposures is generally 15 months. Derivative gains and losses, initially reported as a component of Accumulated other comprehensive income (loss), are reclassified to earnings in the period when the transaction affects earnings. Net Investment Hedges As of June 30, 2020, we had cross-currency swap agreements, with an aggregate notional amount of $198.3 million, to hedge the variability of net assets due to changes in the U.S. dollar-Euro spot exchange rates through July 2023. These cross-currency swaps are designated as net investment hedges of subsidiaries using the Euro as their functional currency. We assess hedge effectiveness under the spot-to-spot method and record changes in fair value attributable to the translation of foreign currencies through Accumulated other comprehensive income (loss). We amortize the impact of all other changes in fair value of the derivatives through Interest expense, which was income of $1.3 million and $3.9 million for both the three and nine months ended June 30, 2020 and 2019. Fair Value We classify fair value measurements on our derivative instruments as Level 2. The estimated fair values of our derivative instruments are described in the table below: Derivative Instruments June 30, 2020 Condensed Consolidated Balance Sheet Position September 30, 2019 Condensed Consolidated Balance Sheet Position Interest Rate Swaps $ — Other assets $ 0.9 Other assets Interest Rate Swaps (49.8) Other current liabilities (7.7) Other current liabilities Currency Exchange Contracts (0.7) Other current liabilities 0.2 Other current assets Cross-Currency Swaps 20.1 Other assets 16.9 Other assets Total $ (30.4) $ 10.3 Undesignated Derivative Instruments We use forward contracts to mitigate the foreign exchange revaluation risk associated with recorded monetary assets and liabilities that are denominated in a non-functional currency. These derivative instruments are not formally designated as hedges and the terms of these instruments generally do not exceed one month. As of June 30, 2020, we had forward contracts not designated as hedges with aggregate notional amounts of $155.4 million. As of September 30, 2019, we had forward contracts not designated as hedges with aggregate notional amounts of $76.7 million. The following table summarizes unrealized and realized gains and losses for forward contracts not designated as hedges, which are recorded in Investment income (expense) and other, net. Three Months Ended June 30 Nine Months Ended June 30 2020 2019 2020 2019 Unrealized gains (losses) $ 0.5 $ 0.5 $ 0.5 $ 0.5 Realized gains (losses) (0.1) (1.3) 1.1 (1.6)

Leases

Leases	9 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Lessee, Operating Leases [Text Block]	Leases Hillrom as the Lessee We determine if an arrangement is a lease or contains a lease at contract inception. We lease real estate, automobiles, and equipment under various operating leases. A lease liability and ROU asset is recognized for operating leases with terms greater than one year at the lease commencement date. The lease liability is measured as the present value of all remaining fixed payments calculated using our estimated secured incremental borrowing rate. The ROU asset is measured as the sum of the lease liability and any initial indirect costs incurred, less any lease incentives received. We use our estimated secured incremental borrowing rate as most lease agreements do not specify an interest rate. Our lease agreements include leases that have both lease and non-lease components. We have elected to account for lease components and the associated non-lease components as a single lease component. Our leases have remaining lease terms of approximately 1 year to 8 years. Many of our real estate and equipment leases include options to renew. Renewal periods are generally not included when calculating the remaining lease term unless we are reasonably certain to exercise a renewal option based on beneficial terms or significance of the leased asset to our operations. Expense for operating leases and leases with a term of one year or less is recognized on a straight-line basis over the lease term. Lease expense is recorded in Cost of goods sold or Selling and administrative expenses based on the purpose of the leased asset. The following table summarizes our lease expense. Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Operating lease expense $ 6.8 $ 20.6 Short-term leases and variable lease payments 3.1 8.7 Total $ 9.9 $ 29.3 The following table summarizes the balance sheet classification of our operating leases and amounts of the ROU asset and lease liability as of June 30, 2020: Balance Sheet Classification June 30, 2020 Right-of-use assets Other assets $ 75.3 Current lease liabilities Other current liabilities 23.1 Non-current lease liabilities Other long-term liabilities 56.8 Supplemental information: June 30, 2020 Weighted-average discount rate 3.3 % Weighted-average remaining lease term in years 4.6 The following table summarizes the maturities of our operating leases as of June 30, 2020: Fiscal Year Amount Remaining 2020 $ 6.8 2021 24.0 2022 18.7 2023 13.4 2024 8.3 2025 5.1 Thereafter 10.1 Total lease payments 86.4 Less: imputed interest (6.5) Total lease liability $ 79.9 Disclosures Related to Periods Prior to Adopting the New Lease Guidance As disclosed in the 2019 Form 10-K, future minimum payments under non-cancellable operating leases (excluding executory costs) aggregating $94.9 million for manufacturing facilities, warehouse distribution centers, service centers, sales offices, automobiles, and other equipment consisted of the following: Fiscal Year Amount 2020 $ 25.7 2021 21.4 2022 15.7 2023 11.1 2024 6.4 2025 and beyond 14.6 Rental expense in fiscal 2019, 2018 and 2017 was $39.8 million, $41.3 million and $38.0 million. Hillrom as the Lessor

Retirement and Postretirement P

Retirement and Postretirement Plans	9 Months Ended
	Jun. 30, 2020
Retirement Benefits [Abstract]
Compensation and Employee Benefit Plans	Retirement and Postretirement Plans We sponsor six defined benefit retirement plans. Those plans include a master defined benefit retirement plan in the United States, a nonqualified supplemental executive defined benefit retirement plan, three defined benefit retirement plans covering employees in Germany and France, and a defined benefit retirement plan of Excel Medical that was acquired on January 10, 2020. Benefits for such plans are based primarily on years of service and the employee’s level of compensation in specific periods of employment. We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time. All of our plans have a September 30 measurement date. The following table details the components of net pension expense for our defined benefit retirement plans. Three Months Ended Nine Months Ended Condensed Consolidated Statements of Income Item 2020 2019 2020 2019 Service cost $ 0.5 $ 0.5 $ 1.3 $ 1.2 Cost of goods sold Service cost 0.9 0.6 2.5 2.1 Selling and administrative expenses Interest cost 1.9 3.1 6.8 9.4 Investment income (expense) and other, net Expected return on plan assets (3.4) (3.7) (10.8) (11.1) Investment income (expense) and other, net Amortization of unrecognized prior service cost, net — 0.1 0.1 0.1 Investment income (expense) and other, net Amortization of net loss 1.9 0.7 5.0 1.8 Investment income (expense) and other, net Settlement loss (gain) (0.1) — 8.4 — Investment income (expense) and other, net Net pension expense $ 1.7 $ 1.3 $ 13.3 $ 3.5 In addition to defined benefit retirement plans, we also offer two postretirement health care plans in the United States that provide health care benefits to qualified retirees and their dependents. The plans are closed to new participants and include retiree cost sharing provisions and generally extend retiree coverage for medical and prescription benefits beyond the COBRA continuation period to the date of Medicare eligibility. Annual costs related to these plans are not significant. On March 9, 2020, we transferred pension assets totaling $40.6 million to purchase annuity contracts for a certain population of retirees with a third-party insurance company. As a result, we recognized a non-cash settlement loss of $8.4 million for the nine months ended June 30, 2020, which is recorded as a component of Investment income (expense) and other, net in the Condensed Consolidated Statements of Income. We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees. The general purpose of these plans is to provide additional financial security in retirement by providing employees with an incentive to regularly save a portion of their earnings. Our contributions to the plans are based on eligibility and, in some cases, employee contributions. Expense under these plans was $7.3 million and $23.6 million for the three and nine months ended June 30, 2020, and $6.9 million and $21.4 million for the three and nine months ended June 30, 2019.

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	9 Months Ended
	Jun. 30, 2020
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss)	Other Comprehensive Income (Loss) The following tables represent the changes in Other comprehensive income (loss) and Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2020 and 2019: Three Months Ended June 30, 2020 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance 2 Derivative instruments designated as hedges 1 : Currency exchange contracts $ 0.4 $ (1.2) $ (0.8) $ 0.2 $ (0.6) $ — $ (0.6) $ (0.6) Interest rate swaps (2.9) (1.7) (4.6) 1.1 (3.5) (34.8) (3.5) (38.3) Cross-currency swaps (3.5) — (3.5) 0.9 (2.6) 16.3 (2.6) 13.7 Derivative instruments designated as hedges total $ (6.0) $ (2.9) $ (8.9) $ 2.2 $ (6.7) $ (18.5) $ (6.7) $ (25.2) Foreign currency translation adjustment 17.1 — 17.1 — 17.1 (153.9) 17.1 (136.8) Change in pension and postretirement defined benefit plans 0.2 1.4 1.6 (0.6) 1.0 (51.2) 1.0 (50.2) Total $ 11.3 $ (1.5) $ 9.8 $ 1.6 $ 11.4 $ (223.6) $ 11.4 $ (212.2) Three Months Ended June 30, 2019 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance Derivative instruments designated as hedges 1 : Currency exchange contracts $ (0.8) $ 0.4 $ (0.4) $ 0.1 $ (0.3) $ 0.4 $ (0.3) $ 0.1 Interest rate swaps (9.0) (1.8) (10.8) 2.5 (8.3) 5.3 (8.3) (3.0) Cross-currency swaps (1.0) — (1.0) 0.2 (0.8) 6.3 (0.8) 5.5 Derivative instruments designated as hedges total $ (10.8) $ (1.4) $ (12.2) $ 2.8 $ (9.4) $ 12.0 $ (9.4) $ 2.6 Foreign currency translation adjustment 4.1 — 4.1 — 4.1 (122.5) 4.1 (118.4) Change in pension and postretirement defined benefit plans — 0.7 0.7 (0.3) 0.4 (29.8) 0.4 (29.4) Total $ (6.7) $ (0.7) $ (7.4) $ 2.5 $ (4.9) $ (140.3) $ (4.9) $ (145.2) The following tables represent the changes in Other comprehensive income (loss) and Accumulated other comprehensive income (loss) by component for the nine months ended June 30, 2020 and 2019: Nine Months Ended June 30, 2020 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance 2 Derivative instruments designated as hedges 1 : Currency exchange contracts $ 0.1 $ (1.1) $ (1.0) $ 0.2 $ (0.8) $ 0.2 $ (0.8) $ (0.6) Interest rate swaps (41.7) (1.3) (43.0) 9.9 (33.1) (5.2) (33.1) (38.3) Cross-currency swaps 1.9 — 1.9 (0.4) 1.5 12.2 1.5 13.7 Derivative instruments designated as hedges total $ (39.7) $ (2.4) $ (42.1) $ 9.7 $ (32.4) $ 7.2 $ (32.4) $ (25.2) Foreign currency translation adjustment 8.6 — 8.6 — 8.6 (145.4) 8.6 (136.8) Change in pension and postretirement defined benefit plans 0.1 (7.7) (7.6) 1.7 (5.9) (44.3) (5.9) (50.2) Total $ (31.0) $ (10.1) $ (41.1) $ 11.4 $ (29.7) $ (182.5) $ (29.7) $ (212.2) Nine Months Ended June 30, 2019 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Impacts of ASU 2018-02 Adoption as of October 1, 2018 Net activity Ending Derivative instruments designated as hedges 1 : Currency exchange contracts $ (0.3) $ 0.2 $ (0.1) $ — $ (0.1) $ 0.2 $ — $ (0.1) $ 0.1 Interest rate swaps (23.2) (5.6) (28.8) 6.7 (22.1) 18.3 0.8 (22.1) (3.0) Cross-currency swaps 9.3 — 9.3 (2.1) 7.2 (1.7) — 7.2 5.5 Derivative instruments designated as hedges total $ (14.2) $ (5.4) $ (19.6) $ 4.6 $ (15.0) $ 16.8 $ 0.8 $ (15.0) $ 2.6 Foreign currency translation adjustment (13.1) — (13.1) — (13.1) (105.3) — (13.1) (118.4) Change in pension and postretirement defined benefit plans 0.1 1.8 1.9 (0.6) 1.3 (24.5) (6.2) 1.3 (29.4) Total $ (27.2) $ (3.6) $ (30.8) $ 4.0 $ (26.8) $ (113.0) $ (5.4) $ (26.8) $ (145.2) 1 See Note 6. Derivative Instruments and Hedging Activity for information regarding our hedging strategies. 2 The estimated net amount of gains and losses reported in Accumulated other comprehensive income (loss) related to our derivative instruments designated as hedges as of June 30, 2020 that are expected to be reclassified into earnings within the next 12 months is expense of $7.7 million. The following table represents the items reclassified out of Accumulated other comprehensive income (loss) and the related tax effects for the three months ended June 30, 2020 and 2019: Three Months Ended June 30 2020 2019 Amount Tax effect Net of tax Amount Tax effect 4 Net of tax Derivative instruments designated as hedges: Currency exchange contracts 1 $ (1.2) $ 0.4 $ (0.8) $ 0.4 $ — $ 0.4 Interest rate swaps 2 (1.7) 0.4 (1.3) (1.8) 0.2 (1.6) Derivative instruments designated as hedges total $ (2.9) $ 0.8 $ (2.1) $ (1.4) $ 0.2 $ (1.2) Change in pension and postretirement defined benefit plans 3 1.4 (0.6) 0.8 0.7 (0.3) 0.4 The following table represents the items reclassified out of Accumulated other comprehensive income (loss) and the related tax effects for the nine months ended June 30, 2020 and 2019: Nine Months Ended June 30 2020 2019 Amount Tax effect Net of tax Amount Tax effect 4 Net of tax Derivative instruments designated as hedges: Currency exchange contracts 1 $ (1.1) $ 0.3 $ (0.8) $ 0.2 $ — $ 0.2 Interest rate swaps 2 (1.3) 0.3 (1.0) (5.6) 1.3 (4.3) Derivative instruments designated as hedges total (2.4) 0.6 (1.8) (5.4) 1.3 (4.1) Change in pension and postretirement defined benefit plans 3 (7.7) 1.7 (6.0) 1.8 (6.8) (5.0) 1 Reclassified from Accumulated other comprehensive income (loss) into Investment income (expense) and other, net. 2 Reclassified from Accumulated other comprehensive income (loss) into Interest expense. 3 Reclassified from Accumulated other comprehensive income (loss) into Cost of goods sold and Investment income (expense) and other, net. These components are included in the computation of net periodic pension expense. 4 As a result of the adoption of ASU 2018-02, we reclassified $5.4 million from Accumulated other comprehensive income (loss) to Retained earnings.

Special Charges

Special Charges	9 Months Ended
	Jun. 30, 2020
Special Charges [Abstract]
Special Charges	Special Charges Special charges are incurred in connection with various transformative initiatives, exit activities, and organizational changes to improve our business alignment and cost structure and are non-recurring in nature. Additional Special charges are expected to be incurred related to restructuring and transformative initiatives in future periods. It is not practicable to estimate the amount of these future expected costs until such time as the evaluations are complete. The following table summarizes the Special charges recognized for the three and nine months ended June 30. Special Charges Three Months Ended June 30 Nine Months Ended June 30 2020 2019 2020 2019 Global information technology transformation $ 6.7 $ — $ 15.3 $ — Exit activity costs: Integration-related activities 2.4 4.7 9.2 11.2 Site consolidation 0.4 1.5 1.6 6.5 Total Special Charges $ 9.5 $ 6.2 $ 26.1 $ 17.7 Global Information Technology Transformation Management pursues opportunities to align our operations to achieve synergies and position the business for growth. In fiscal 2018, a global transformation program was launched that was focused on reducing complexity, increasing efficiency, and improving our cost structure with targeted investments that align with our strategic priorities. As part of this program, management launched an initiative related to a global information technology transformation, including rationalizing and transforming our enterprise resource planning software solutions and other complementary information technology systems. For the three months ended June 30, 2020, we incurred $9.0 million related to this initiative of which $2.3 million was capitalized and $6.7 million was expensed in Special charges. For the nine months ended June 30, 2020, we incurred $28.3 million related to this initiative of which $13.0 million was capitalized and $15.3 million was expensed in Special charges. The objective of this initiative is to consolidate and streamline our key workstreams that interact with customers and vendors and support our financial reporting processes while maintaining the security of our data. The solutions designed under this initiative will be implemented over the next five to seven years. Integration-Related Activities We incurred costs, including severance and benefit costs, associated with other business realignment and integration activities. We acquired several businesses in fiscal 2019 and 2020 as disclosed within Note 4. Business Combinations for which we also continue to incur integration-related costs and severance costs. Site Consolidation We continue to streamline our operations and simplify our supply chain by consolidating certain manufacturing and distribution operations (“Site Consolidation”). For all accrued severance and other benefit charges described above, we record reserves within Other current liabilities. The reserve activity for severance and other benefits for the nine months ended June 30, 2020 was as follows: Balance as of September 30, 2019 $ 8.5 Expenses 4.9 Cash payments (9.6) Reversals (0.5) Balance as of June 30, 2020 $ 3.3

Income Taxes

Income Taxes	9 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective tax rate for the three months ended June 30, 2020 was 21.9% compared to 28.7% for the comparable period in the prior year. The effective tax rate for the three months ended June 30, 2020 was favorably impacted primarily by an increased projected benefit for the deduction attributed to foreign derived intangible income (“FDII”) as well as larger unfavorable impacts from discrete items in the prior comparable period. The effective tax rate for the nine months ended June 30, 2020 was 17.8% compared to 20.3% for the comparable period in the prior year. The effective tax rate for the nine months ended June 30, 2020 was favorably impacted primarily by an increased projected benefit for the deduction attributed to FDII as well as a small benefit from current year discrete items. The effective tax rate for the nine months ended June 30, 2020 was also favorably impacted by the reduction of the contingent consideration accrual of $8.4 million, that is not subject to tax.

Earnings per Common Share

Earnings per Common Share	9 Months Ended
	Jun. 30, 2020
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share Basic earnings per share (“EPS”) is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares. Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs. For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share. Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding. Earnings per share are calculated as follows: Three Months Ended June 30 Nine Months Ended June 30 2020 2019 2020 2019 Net Income $ 93.9 $ 32.6 $ 180.6 $ 124.3 Net Income per Basic Common Share $ 1.41 $ 0.49 $ 2.71 $ 1.86 Net Income per Diluted Common Share $ 1.40 $ 0.48 $ 2.68 $ 1.84 Average Basic Common Shares Outstanding (in thousands) 66,558 66,777 66,660 66,822 Add potential effect of exercise of stock options and other unvested equity awards 625 669 632 662 Average Diluted Common Shares Outstanding (in thousands) 67,183 67,446 67,292 67,484 Shares with anti-dilutive effect excluded from the computation of diluted EPS 291 258 298 299

Guarantees

Guarantees	9 Months Ended
	Jun. 30, 2020
Product Warranties Disclosures [Abstract]
Guarantees	Warranties and Guarantees We routinely grant limited warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods. We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve. The amount of the warranty reserve is determined based on historical trend experience for the covered products. For more significant warranty-related matters that might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated. The following summarizes accrued product warranty activity for the three and nine months ended June 30, 2020. Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Balance as of beginning of period $ 29.0 $ 29.7 Provision for warranties in the period 5.2 13.0 Warranty claims in the period (3.7) (12.2) Balance as of end of period $ 30.5 $ 30.5 In the normal course of business, we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners, and others. Examples of these arrangements would include guarantees of product performance, indemnifications to service providers, and indemnifications of our actions to business partners. These guarantees and indemnifications have not historically had a material impact on our financial condition or results of operations, nor do we expect them to, although indemnifications associated with our actions generally have no dollar limitations. In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations, and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.

Segment Reporting

Segment Reporting	9 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting We disclose segment information that is consistent with the way in which management operates and views the business. Our operating structure contains the following reportable segments: • Patient Support Systems – globally provides our med-surg and specialty bed systems and surfaces, safe patient handling equipment and mobility solutions, as well as our care communications platform that delivers software and information technologies to improve care and deliver actionable insight to caregivers and patients. • Front Line Care – globally provides patient monitoring and diagnostic technologies, including a diversified portfolio of physical assessment tools that help diagnose, treat and manage a wide variety of illnesses and diseases, including respiratory and a portfolio of vision care health devices. • Surgical Solutions – globally provides products that improve safety and efficiency in the surgical space, including tables, lights, pendants, precision positioning devices, and other accessories. Our performance within each reportable segment continues to be measured on a divisional income basis before non-allocated operating and administrative costs, litigation, special charges, acquisition and integration costs, acquisition-related intangible asset amortization, and other unusual events. Divisional income generally represents the division’s gross profit, excluding acquisition-related intangible asset amortization, less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development, and certain corporate functional expenses. Non-allocated operating costs, administrative costs, and other includes functional expenses that support the entire organization such as administration, finance, legal and human resources, expenses associated with strategic developments, acquisition-related intangible asset amortization, and other events that are not indicative of operating trends. We exclude such amounts from divisional income to allow management to evaluate and understand divisional operating trends. The chief operating decision maker does not receive any asset information by reportable segment and, accordingly, we do not report asset information by reportable segment. Effective for fiscal 2020, the allocation of operating costs to each segment was modified to improve the alignment to how management evaluates the performance of each segment. The fiscal 2019 segment information has been recast to conform to the current presentation. The reclassification did not impact our reported Consolidated Net Revenue or Income Before Income Taxes. Three Months Ended June 30 Nine Months Ended June 30 2020 2019 2020 2019 Net Revenue - United States: Patient Support Systems $ 316.9 $ 290.8 $ 872.8 $ 806.1 Front Line Care 167.8 178.4 525.2 515.1 Surgical Solutions 22.5 60.2 97.6 169.7 Total net revenue - United States $ 507.2 $ 529.4 $ 1,495.6 $ 1,490.9 Net Revenue - Outside of the United States (“OUS”): Patient Support Systems $ 130.9 $ 83.7 $ 301.2 $ 269.0 Front Line Care 84.3 66.0 239.8 205.8 Surgical Solutions 45.1 47.7 139.1 158.8 Total net revenue - OUS $ 260.3 $ 197.4 $ 680.1 $ 633.6 Net Revenue: Patient Support Systems $ 447.8 $ 374.5 $ 1,174.0 $ 1,075.1 Front Line Care 252.1 244.4 765.0 720.9 Surgical Solutions 67.6 107.9 236.7 328.5 Total net revenue $ 767.5 $ 726.8 $ 2,175.7 $ 2,124.5 Divisional Income: Patient Support Systems $ 129.2 $ 83.5 $ 262.4 $ 215.4 Front Line Care 81.1 69.5 232.5 198.5 Surgical Solutions 4.7 17.8 31.0 44.2 Other Operating Costs: Non-allocated operating costs, administrative costs, and other 70.2 94.7 198.3 218.4 Special charges 9.5 6.2 26.1 17.7 Operating Profit 135.3 69.9 301.5 222.0 Interest expense (17.3) (23.1) (55.8) (66.2) Loss on extinguishment of debt — — (15.6) — Investment income (expense) and other, net 2.2 (1.1) (10.5) 0.2 Income Before Income Taxes $ 120.2 $ 45.7 $ 219.6 $ 156.0

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies General We are subject to various claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental and other matters. Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance. It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a materially adverse effect on our financial condition, results of operations and cash flows. Self-Insurance We are involved in various claims, including product and general liability, workers’ compensation, auto liability and employment related matters. Such claims in the United States have deductibles and self-insured retentions at various limits up to $1.0 million per occurrence or per claim, depending upon the type of coverage and policy period. International deductibles and self-insured retentions are lower. We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug, and dental. Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other current liabilities and Other long-term liabilities.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies Nature of Operations (Policies)	9 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Use of Estimates	The Company makes a number of significant estimates, assumptions, and judgments in the preparation of its financial statements. Additionally, the Company measures and classifies fair value measurements in accordance with the level hierarchy in conformity with accounting principles generally accepted in the United States (“GAAP”). As of June 30, 2020, the Company's significant accounting policies and estimates and valuation techniques used to measure fair value have not changed from September 30, 2019. See Note 1. Summary of Significant Accounting Policies within the 2019 Form 10-K for the fiscal year ended September 30, 2019 for further information.
Recently Issued Accounting Standards	Recently Adopted Accounting Standards In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) and subsequently issued related amendments, collectively referred to as “ASC 842”. The objective of this guidance is to increase transparency and comparability among organizations through recognizing leased assets, called right-of-use assets (“ROU”), and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. As a lessee, the new standard requires us to recognize both the ROU assets and lease liabilities in the balance sheet for most leases, whereas under previous GAAP only finance lease liabilities (referred to as capital leases) were recognized in the balance sheet. In addition, for both lessees and lessors, the definition of a lease has been revised, which may result in changes to the classification of an arrangement as a lease. Under the new standard, an arrangement that conveys the right to control the use of an identified asset by obtaining substantially all of its economic benefits and directing how it is used is a lease, whereas the previous definition focused on the ability to control the use of the asset or to obtain its output. Quantitative and qualitative disclosures related to the amount, timing and judgments of an entity’s accounting for leases and the related cash flows are expanded under the new standard. Disclosure requirements apply to both lessees and lessors, whereas previous disclosures related only to lessees. The recognition, measurement, and presentation of revenues, expenses, and cash flows arising from a lease have not significantly changed from previous GAAP. We adopted ASC 842 effective October 1, 2019 using the optional transition method approach. We elected the package of practical expedients, which applies to both lessees and lessors, to (1) not reassess whether existing contracts contain leases, (2) carryforward the existing lease classification, and (3) not reassess initial direct costs associated with existing leases. As a lessee, the adoption of the guidance on October 1, 2019 resulted in the recognition of ROU assets of $82.5 million and lease liabilities of $85.8 million, which all related to operating leases. The ROU assets were lower than the lease liabilities due to the derecognition of deferred rent balances of $3.3 million. As a lessor, there was no impact as a result of the adoption. We did not recognize any adjustment to the comparative period presented in the financial statements in accordance with our adoption method. The guidance did not have a material impact on our Condensed Consolidated Statements of Income. See Note 7. Leases for additional information on the impacts of ASC 842. In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This standard eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. ASU 2017-04 is effective for our first quarter of fiscal 2021 and requires a prospective transition method. Early adoption is permitted. We early adopted this standard in the first quarter of fiscal 2020 and the guidance did not have a material impact on our Condensed Consolidated Financial Statements. In October 2018, the FASB issued ASU 2018-16, Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes . The purpose of the standard is to allow the use of the OIS rate based on the SOFR for hedge accounting purposes, which allows entities to designate changes in the fair values of fixed-rate financial assets or liabilities attributable to the OIS rate as the hedged risk. The amendment recognizes the OIS rate based on the SOFR as likely London Interbank Offered Rate (“LIBOR”) replacements and supports the marketplace transition by adding the new reference rate as a benchmark rate. We adopted this standard in the first quarter of fiscal 2020. The adoption of this ASU did not impact our financial statements as we have not yet utilized the OIS rate based on the SOFR for borrowings under our lending arrangements or as a benchmark rate for hedge accounting purposes. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The purpose of the standard is to provide guidance for the effects of the marketplace transition from LIBOR to a new reference rate as a benchmark rate. ASU 2020-04 is optional and is effective for a limited period of time from March 12, 2020 through December 31, 2022. We will continue to monitor, assess, and plan for the phase out of LIBOR. Recently Issued Accounting Standards In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments and subsequently issued related amendments, collectively referred to as “Topic 326”. Topic 326 requires entities to measure credit losses for financial assets measured at amortized cost based on expected losses rather than incurred losses. For available-for-sale debt securities with unrealized losses, entities will recognize credit losses through an allowance for credit losses. Topic 326 is effective for our first quarter of fiscal 2021 and requires a prospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement . The purpose of the standard is to improve the overall usefulness of fair value disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-13 is effective for our first quarter of fiscal 2021 and requires the application of the prospective method of transition (for only the most recent interim or annual period presented in the initial fiscal year of adoption) to the new disclosure requirements for (1) changes in unrealized gains and losses included in other comprehensive income and (2) the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU 2018-13 also requires prospective application to any modifications to disclosures made because of the change to the requirements for the narrative description of measurement uncertainty. The effects of all other amendments made by ASU 2018-13 must be applied retrospectively to all periods presented. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits – Defined Benefit Plans – General (Topic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans. The purpose of the standard is to improve the overall usefulness of defined benefit pension and other postretirement plan disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-14 is effective for our annual disclosures for fiscal 2021 and requires a retrospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-15, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract . This update aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement to be consistent with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). ASU 2018-15 is effective for our first quarter of fiscal 2021 and allows a retrospective or a prospective transition method to all implementation costs incurred after the date of adoption. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 . The purpose of the standard is to (1) clarify that transactions between participants in a collaborative agreement should be accounted for under Topic 606 and (2) add unit-of-account guidance in Topic 808 to align with Topic 606. ASU 2018-18 is effective for our first quarter of fiscal 2021 and must be applied retrospectively to the first quarter of fiscal 2020. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The purpose of the standard is to remove certain exceptions to the general principles of Topic 740: Income Taxes in order to reduce the cost and complexity of its application and to maintain or improve the usefulness of the information provided to users of financial statements. ASU 2019-12 is effective for our first quarter of fiscal 2022 and will be applied either retrospectively or prospectively depending on the specific Topic 740 exception affected. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. Except as noted above, there are no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1. Summary of Significant Accounting Policies of our Consolidated Financial Statements in our 2019 Form 10-K.
Basis of Presentation and Principles of Consolidation	The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in Hillrom’s latest fiscal 2019 Form 10-K as filed with the SEC. The September 30, 2019 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements but does not include all disclosures required by accounting principles generally accepted in the United States. In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments necessary to state fairly the financial position, results of operations, and cash flows for the interim periods presented. Quarterly results are not necessarily indicative of annual results.The Condensed Consolidated Financial Statements include the accounts of Hillrom and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.

Accounting Policies (Tables)

Accounting Policies (Tables)	9 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Prior Period Reclassification	The following table presents Acquisition-related intangible asset amortization and Selling and administrative expenses, excluding the Acquisition-related intangible asset amortization, for the years ended September 30, 2019, 2018 and 2017, and for each quarterly period of fiscal 2019. Quarter Ended Year Ended December 31, March 31, June 30, September 30, September 30, September 30, September 30, Selling and administrative expense, previously reported $ 218.0 $ 231.2 $ 246.4 $ 245.4 $ 941.0 $ 891.6 $ 874.5 Less, Acquisition-related intangible asset amortization 25.7 27.3 29.3 40.1 122.4 106.9 108.4 Selling and administrative expense, currently reported $ 192.3 $ 203.9 $ 217.1 $ 205.3 $ 818.6 $ 784.7 $ 766.1

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Jun. 30, 2020
Revenue from Contract with Customer [Abstract]
Contract with Customer, Asset and Liability [Table Text Block]	The following summarizes contract liability activity for the nine months ended June 30, 2020. The contract liability balance represents the transaction price allocated to the remaining performance obligations. Contract Liabilities Balance as of September 30, 2019 125.8 Deferred revenue acquired 2.7 New revenue deferrals 220.4 Revenue recognized upon satisfaction of performance obligations (214.1) Balance as of June 30, 2020 $ 134.8

Supplementary Balance Sheet I_2

Supplementary Balance Sheet Information (Tables)	9 Months Ended
	Jun. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Supplementary Balance Sheet Information	June 30, September 30, 2019 Inventories, net of reserves: Finished products $ 143.1 $ 120.5 Work in process 49.6 42.4 Raw materials 130.1 106.7 Total inventories, net of reserves $ 322.8 $ 269.6 Accumulated amortization of software and other intangible assets $ 635.7 $ 597.0 Investments included in Other assets $ 47.6 $ 51.1
Schedule of Cash Flow, Supplemental Disclosures	Supplemental Cash Flow Information Nine Months Ended June 30 2020 2019 Non-cash investing activities: Change in capital expenditures not paid $ 1.8 $ 2.3 Sale of equity method investment 2.1 — Total non-cash investing activities: $ 3.9 $ 2.3 Non-cash financing activities: Distribution of shares issued under stock-based compensation plans $ 29.6 $ 10.4

Business Combinations Acquisiti

Business Combinations Acquisitions (Tables)	9 Months Ended
	Jun. 30, 2020
Business Combination [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The following table summarizes the preliminary estimate of the fair value of assets acquired and liabilities assumed at the date of the Excel Medical acquisition. The fair values of assets acquired and liabilities assumed are still considered to be preliminary, however we do not expect further adjustments to be significant. Amount Trade accounts receivable $ 0.6 Inventories 0.9 Other current assets 0.1 Property, plant and equipment 0.1 Goodwill 9.8 Developed technology 10.9 Deferred revenue (2.7) Other current liabilities (0.5) Total purchase price, net of cash acquired $ 19.2 The following table summarizes the preliminary estimate of the fair value of assets acquired and liabilities assumed at the date of the Breathe acquisition. The fair value of assets acquired and liabilities assumed are still considered to be preliminary, however we do not expect further adjustments to be significant. Amount Trade accounts receivable $ 0.3 Inventories 6.3 Other current assets 0.1 Property, plant and equipment 2.1 Goodwill 60.2 Trade name 4.0 Customer relationships 0.4 Developed technology 56.0 Other assets 0.2 Trade accounts payable (0.5) Other current liabilities (1.6) Deferred income taxes 0.9 Other long-term liabilities (0.8) Total purchase price, net of cash acquired $ 127.6 The following table summarizes the fair value of assets acquired and liabilities assumed at the date of the Voalte acquisition. Amount Trade accounts receivable $ 5.8 Inventories 0.1 Other current assets 2.7 Property, plant and equipment 0.2 Goodwill 98.5 Non-competition agreements 2.7 Trade name 13.5 Customer relationships 29.0 Developed technology 55.0 Trade accounts payable (1.7) Deferred revenue (10.7) Other current liabilities (4.3) Deferred income taxes (9.8) Total purchase price, net of cash acquired $ 181.0

Financing Agreements (Tables)

Financing Agreements (Tables)	9 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Schedule of Fair Values of Long-Term Debt Instruments	The estimated fair values of our long-term debt instruments are described in the table below: June 30, September 30, 2019 Senior unsecured 5.00% notes due on February 14, 2025 $ 310.5 $ 312.4 Senior unsecured 4.375% notes due on September 15, 2027 435.4 435.4 Unsecured debentures 47.0 48.1 Total $ 792.9 $ 795.9

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
	Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The estimated fair values of our derivative instruments are described in the table below: Derivative Instruments June 30, 2020 Condensed Consolidated Balance Sheet Position September 30, 2019 Condensed Consolidated Balance Sheet Position Interest Rate Swaps $ — Other assets $ 0.9 Other assets Interest Rate Swaps (49.8) Other current liabilities (7.7) Other current liabilities Currency Exchange Contracts (0.7) Other current liabilities 0.2 Other current assets Cross-Currency Swaps 20.1 Other assets 16.9 Other assets Total $ (30.4) $ 10.3
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location	The following table summarizes unrealized and realized gains and losses for forward contracts not designated as hedges, which are recorded in Investment income (expense) and other, net. Three Months Ended June 30 Nine Months Ended June 30 2020 2019 2020 2019 Unrealized gains (losses) $ 0.5 $ 0.5 $ 0.5 $ 0.5 Realized gains (losses) (0.1) (1.3) 1.1 (1.6)

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Lease, Cost [Table Text Block]	The following table summarizes our lease expense. Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Operating lease expense $ 6.8 $ 20.6 Short-term leases and variable lease payments 3.1 8.7 Total $ 9.9 $ 29.3
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	The following table summarizes the maturities of our operating leases as of June 30, 2020: Fiscal Year Amount Remaining 2020 $ 6.8 2021 24.0 2022 18.7 2023 13.4 2024 8.3 2025 5.1 Thereafter 10.1 Total lease payments 86.4 Less: imputed interest (6.5) Total lease liability $ 79.9
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	As disclosed in the 2019 Form 10-K, future minimum payments under non-cancellable operating leases (excluding executory costs) aggregating $94.9 million for manufacturing facilities, warehouse distribution centers, service centers, sales offices, automobiles, and other equipment consisted of the following: Fiscal Year Amount 2020 $ 25.7 2021 21.4 2022 15.7 2023 11.1 2024 6.4 2025 and beyond 14.6
Lessee, Operating Lease, Disclosure	The following table summarizes the balance sheet classification of our operating leases and amounts of the ROU asset and lease liability as of June 30, 2020: Balance Sheet Classification June 30, 2020 Right-of-use assets Other assets $ 75.3 Current lease liabilities Other current liabilities 23.1 Non-current lease liabilities Other long-term liabilities 56.8 Supplemental information: June 30, 2020 Weighted-average discount rate 3.3 % Weighted-average remaining lease term in years 4.6

Retirement and Postretirement_2

Retirement and Postretirement Plans (Tables)	9 Months Ended
	Jun. 30, 2020
Retirement Benefits [Abstract]
Schedule of Components of Net Pension Expense	The following table details the components of net pension expense for our defined benefit retirement plans. Three Months Ended Nine Months Ended Condensed Consolidated Statements of Income Item 2020 2019 2020 2019 Service cost $ 0.5 $ 0.5 $ 1.3 $ 1.2 Cost of goods sold Service cost 0.9 0.6 2.5 2.1 Selling and administrative expenses Interest cost 1.9 3.1 6.8 9.4 Investment income (expense) and other, net Expected return on plan assets (3.4) (3.7) (10.8) (11.1) Investment income (expense) and other, net Amortization of unrecognized prior service cost, net — 0.1 0.1 0.1 Investment income (expense) and other, net Amortization of net loss 1.9 0.7 5.0 1.8 Investment income (expense) and other, net Settlement loss (gain) (0.1) — 8.4 — Investment income (expense) and other, net Net pension expense $ 1.7 $ 1.3 $ 13.3 $ 3.5

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Jun. 30, 2020
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in AOCL by Component	The following tables represent the changes in Other comprehensive income (loss) and Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2020 and 2019: Three Months Ended June 30, 2020 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance 2 Derivative instruments designated as hedges 1 : Currency exchange contracts $ 0.4 $ (1.2) $ (0.8) $ 0.2 $ (0.6) $ — $ (0.6) $ (0.6) Interest rate swaps (2.9) (1.7) (4.6) 1.1 (3.5) (34.8) (3.5) (38.3) Cross-currency swaps (3.5) — (3.5) 0.9 (2.6) 16.3 (2.6) 13.7 Derivative instruments designated as hedges total $ (6.0) $ (2.9) $ (8.9) $ 2.2 $ (6.7) $ (18.5) $ (6.7) $ (25.2) Foreign currency translation adjustment 17.1 — 17.1 — 17.1 (153.9) 17.1 (136.8) Change in pension and postretirement defined benefit plans 0.2 1.4 1.6 (0.6) 1.0 (51.2) 1.0 (50.2) Total $ 11.3 $ (1.5) $ 9.8 $ 1.6 $ 11.4 $ (223.6) $ 11.4 $ (212.2) Three Months Ended June 30, 2019 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance Derivative instruments designated as hedges 1 : Currency exchange contracts $ (0.8) $ 0.4 $ (0.4) $ 0.1 $ (0.3) $ 0.4 $ (0.3) $ 0.1 Interest rate swaps (9.0) (1.8) (10.8) 2.5 (8.3) 5.3 (8.3) (3.0) Cross-currency swaps (1.0) — (1.0) 0.2 (0.8) 6.3 (0.8) 5.5 Derivative instruments designated as hedges total $ (10.8) $ (1.4) $ (12.2) $ 2.8 $ (9.4) $ 12.0 $ (9.4) $ 2.6 Foreign currency translation adjustment 4.1 — 4.1 — 4.1 (122.5) 4.1 (118.4) Change in pension and postretirement defined benefit plans — 0.7 0.7 (0.3) 0.4 (29.8) 0.4 (29.4) Total $ (6.7) $ (0.7) $ (7.4) $ 2.5 $ (4.9) $ (140.3) $ (4.9) $ (145.2) The following tables represent the changes in Other comprehensive income (loss) and Accumulated other comprehensive income (loss) by component for the nine months ended June 30, 2020 and 2019: Nine Months Ended June 30, 2020 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance 2 Derivative instruments designated as hedges 1 : Currency exchange contracts $ 0.1 $ (1.1) $ (1.0) $ 0.2 $ (0.8) $ 0.2 $ (0.8) $ (0.6) Interest rate swaps (41.7) (1.3) (43.0) 9.9 (33.1) (5.2) (33.1) (38.3) Cross-currency swaps 1.9 — 1.9 (0.4) 1.5 12.2 1.5 13.7 Derivative instruments designated as hedges total $ (39.7) $ (2.4) $ (42.1) $ 9.7 $ (32.4) $ 7.2 $ (32.4) $ (25.2) Foreign currency translation adjustment 8.6 — 8.6 — 8.6 (145.4) 8.6 (136.8) Change in pension and postretirement defined benefit plans 0.1 (7.7) (7.6) 1.7 (5.9) (44.3) (5.9) (50.2) Total $ (31.0) $ (10.1) $ (41.1) $ 11.4 $ (29.7) $ (182.5) $ (29.7) $ (212.2) Nine Months Ended June 30, 2019 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Impacts of ASU 2018-02 Adoption as of October 1, 2018 Net activity Ending Derivative instruments designated as hedges 1 : Currency exchange contracts $ (0.3) $ 0.2 $ (0.1) $ — $ (0.1) $ 0.2 $ — $ (0.1) $ 0.1 Interest rate swaps (23.2) (5.6) (28.8) 6.7 (22.1) 18.3 0.8 (22.1) (3.0) Cross-currency swaps 9.3 — 9.3 (2.1) 7.2 (1.7) — 7.2 5.5 Derivative instruments designated as hedges total $ (14.2) $ (5.4) $ (19.6) $ 4.6 $ (15.0) $ 16.8 $ 0.8 $ (15.0) $ 2.6 Foreign currency translation adjustment (13.1) — (13.1) — (13.1) (105.3) — (13.1) (118.4) Change in pension and postretirement defined benefit plans 0.1 1.8 1.9 (0.6) 1.3 (24.5) (6.2) 1.3 (29.4) Total $ (27.2) $ (3.6) $ (30.8) $ 4.0 $ (26.8) $ (113.0) $ (5.4) $ (26.8) $ (145.2) 1 See Note 6. Derivative Instruments and Hedging Activity for information regarding our hedging strategies. 2 The estimated net amount of gains and losses reported in Accumulated other comprehensive income (loss) related to our derivative instruments designated as hedges as of June 30, 2020 that are expected to be reclassified into earnings within the next 12 months is expense of $7.7 million.
Schedule of Items Reclassified out of AOCL	The following table represents the items reclassified out of Accumulated other comprehensive income (loss) and the related tax effects for the three months ended June 30, 2020 and 2019: Three Months Ended June 30 2020 2019 Amount Tax effect Net of tax Amount Tax effect 4 Net of tax Derivative instruments designated as hedges: Currency exchange contracts 1 $ (1.2) $ 0.4 $ (0.8) $ 0.4 $ — $ 0.4 Interest rate swaps 2 (1.7) 0.4 (1.3) (1.8) 0.2 (1.6) Derivative instruments designated as hedges total $ (2.9) $ 0.8 $ (2.1) $ (1.4) $ 0.2 $ (1.2) Change in pension and postretirement defined benefit plans 3 1.4 (0.6) 0.8 0.7 (0.3) 0.4 The following table represents the items reclassified out of Accumulated other comprehensive income (loss) and the related tax effects for the nine months ended June 30, 2020 and 2019: Nine Months Ended June 30 2020 2019 Amount Tax effect Net of tax Amount Tax effect 4 Net of tax Derivative instruments designated as hedges: Currency exchange contracts 1 $ (1.1) $ 0.3 $ (0.8) $ 0.2 $ — $ 0.2 Interest rate swaps 2 (1.3) 0.3 (1.0) (5.6) 1.3 (4.3) Derivative instruments designated as hedges total (2.4) 0.6 (1.8) (5.4) 1.3 (4.1) Change in pension and postretirement defined benefit plans 3 (7.7) 1.7 (6.0) 1.8 (6.8) (5.0) 1 Reclassified from Accumulated other comprehensive income (loss) into Investment income (expense) and other, net. 2 Reclassified from Accumulated other comprehensive income (loss) into Interest expense. 3 Reclassified from Accumulated other comprehensive income (loss) into Cost of goods sold and Investment income (expense) and other, net. These components are included in the computation of net periodic pension expense. 4 As a result of the adoption of ASU 2018-02, we reclassified $5.4 million from Accumulated other comprehensive income (loss) to Retained earnings.

Special Charges (Tables)

Special Charges (Tables)	9 Months Ended
	Jun. 30, 2020
Special Charges [Abstract]
Restructuring Activity	The reserve activity for severance and other benefits for the nine months ended June 30, 2020 was as follows: Balance as of September 30, 2019 $ 8.5 Expenses 4.9 Cash payments (9.6) Reversals (0.5) Balance as of June 30, 2020 $ 3.3
Special Charges, Net	The following table summarizes the Special charges recognized for the three and nine months ended June 30. Special Charges Three Months Ended June 30 Nine Months Ended June 30 2020 2019 2020 2019 Global information technology transformation $ 6.7 $ — $ 15.3 $ — Exit activity costs: Integration-related activities 2.4 4.7 9.2 11.2 Site consolidation 0.4 1.5 1.6 6.5 Total Special Charges $ 9.5 $ 6.2 $ 26.1 $ 17.7

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	9 Months Ended
	Jun. 30, 2020
Earnings Per Share [Abstract]
Calculated Earnings per Share	Earnings per share are calculated as follows: Three Months Ended June 30 Nine Months Ended June 30 2020 2019 2020 2019 Net Income $ 93.9 $ 32.6 $ 180.6 $ 124.3 Net Income per Basic Common Share $ 1.41 $ 0.49 $ 2.71 $ 1.86 Net Income per Diluted Common Share $ 1.40 $ 0.48 $ 2.68 $ 1.84 Average Basic Common Shares Outstanding (in thousands) 66,558 66,777 66,660 66,822 Add potential effect of exercise of stock options and other unvested equity awards 625 669 632 662 Average Diluted Common Shares Outstanding (in thousands) 67,183 67,446 67,292 67,484 Shares with anti-dilutive effect excluded from the computation of diluted EPS 291 258 298 299

Guarantees (Tables)

Guarantees (Tables)	9 Months Ended
	Jun. 30, 2020
Product Warranties Disclosures [Abstract]
Reconciliation of Changes in the Warranty Reserve	The following summarizes accrued product warranty activity for the three and nine months ended June 30, 2020. Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Balance as of beginning of period $ 29.0 $ 29.7 Provision for warranties in the period 5.2 13.0 Warranty claims in the period (3.7) (12.2) Balance as of end of period $ 30.5 $ 30.5

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Reconciliation of Segment Information to Consolidated Financial Information	Three Months Ended June 30 Nine Months Ended June 30 2020 2019 2020 2019 Net Revenue - United States: Patient Support Systems $ 316.9 $ 290.8 $ 872.8 $ 806.1 Front Line Care 167.8 178.4 525.2 515.1 Surgical Solutions 22.5 60.2 97.6 169.7 Total net revenue - United States $ 507.2 $ 529.4 $ 1,495.6 $ 1,490.9 Net Revenue - Outside of the United States (“OUS”): Patient Support Systems $ 130.9 $ 83.7 $ 301.2 $ 269.0 Front Line Care 84.3 66.0 239.8 205.8 Surgical Solutions 45.1 47.7 139.1 158.8 Total net revenue - OUS $ 260.3 $ 197.4 $ 680.1 $ 633.6 Net Revenue: Patient Support Systems $ 447.8 $ 374.5 $ 1,174.0 $ 1,075.1 Front Line Care 252.1 244.4 765.0 720.9 Surgical Solutions 67.6 107.9 236.7 328.5 Total net revenue $ 767.5 $ 726.8 $ 2,175.7 $ 2,124.5 Divisional Income: Patient Support Systems $ 129.2 $ 83.5 $ 262.4 $ 215.4 Front Line Care 81.1 69.5 232.5 198.5 Surgical Solutions 4.7 17.8 31.0 44.2 Other Operating Costs: Non-allocated operating costs, administrative costs, and other 70.2 94.7 198.3 218.4 Special charges 9.5 6.2 26.1 17.7 Operating Profit 135.3 69.9 301.5 222.0 Interest expense (17.3) (23.1) (55.8) (66.2) Loss on extinguishment of debt — — (15.6) — Investment income (expense) and other, net 2.2 (1.1) (10.5) 0.2 Income Before Income Taxes $ 120.2 $ 45.7 $ 219.6 $ 156.0

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended					9 Months Ended		12 Months Ended
	Jun. 30, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017	Oct. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating Lease, Liability	$ 79,900,000					$ 79,900,000
Operating Lease, Right-of-Use Asset	75,300,000					75,300,000
Selling and administrative expenses	202,300,000	$ 245,400,000	$ 246,400,000	$ 231,200,000	$ 218,000,000	609,000,000		$ 941,000,000	$ 891,600,000	$ 874,500,000
Acquisition-related intangible asset amortization		40,100,000	29,300,000	27,300,000	25,700,000	81,300,000	$ 82,300,000	122,400,000	106,900,000	108,400,000
Selling and administrative expense, revised		$ 205,300,000	$ 217,100,000	$ 203,900,000	$ 192,300,000		613,300,000	$ 818,600,000	$ 784,700,000	$ 766,100,000
Government Grants and Cost Abatement's	2,400,000
Cares Act	$ 6,900,000					$ 6,900,000
Accounting Standards Update 2016-02 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating Lease, Liability											$ 85,800,000
Operating Lease, Right-of-Use Asset											82,500,000
Deferred Rent Credit, Noncurrent											$ 3,300,000
Accounting Standards Update 2016-16 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative Effect on Retained Earnings, Net of Tax							$ (5,600,000)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Other Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	Aug. 02, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Accounting Policies [Abstract]
Revenues		$ 767.5	$ 726.8	$ 2,175.7	$ 2,124.5
Sale of businesses	$ 166.6
Net Income (Loss) Attributable to Parent		93.9	32.6	180.6	124.3
Net Income		$ 93.9	$ 32.6	$ 180.6	$ 124.3
Net Income Attributable to Common Shareholders per Common Share - Basic (usd per share)		$ 1.41	$ 0.49	$ 2.71	$ 1.86
Earnings Per Share, Diluted		$ 1.40	$ 0.48	$ 2.68	$ 1.84

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2020	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
Other Liabilities and Deferred Revenue, Noncurrent	$ 134.8	$ 125.8
Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized	(214.1)
Deferred Revenue	106.7	$ 107.3
Deferred Revenue, Additions	220.4
Capitalized Contract Cost [Line Items]
Deferred Revenue, Additions	220.4
Voalte [Member]
Revenue from Contract with Customer [Abstract]
Deferred Revenue, Additions	2.7
Capitalized Contract Cost [Line Items]
Deferred Revenue, Additions	$ 2.7

Supplementary Balance Sheet I_3

Supplementary Balance Sheet Information (Details) - USD ($)	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2018
Inventories, net of reserves:
Finished products	$ 143,100,000		$ 120,500,000
Inventory, Work in Process, Gross	49,600,000		42,400,000
Inventory, Raw Materials, Net of Reserves	130,100,000		106,700,000
Total inventories, net of reserves	322,800,000		269,600,000
Accumulated amortization of software and other intangible assets	635,700,000		597,000,000
Equity Securities without Readily Determinable Fair Value, Amount				$ 26,600,000
Equity Method Investment, Aggregate Cost	3,100,000
Loss on Sale of Investments	(300,000)
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net	(1,700,000)
Investments	47,600,000		$ 51,100,000
Capital Expenditures Incurred but Not yet Paid	1,800,000	$ 2,300,000
Equity Method Investment, Realized Gain (Loss) on Disposal	2,100,000
Non-cash Investing Activities	3,900,000	2,300,000
Restricted Stock or Unit Expense	$ 29,600,000	$ 10,400,000

Business Combinations Acquisi_2

Business Combinations Acquisitions (Details) - USD ($)

Jul. 21, 2020

May 18, 2020

Jan. 10, 2020

Sep. 03, 2019

Aug. 02, 2019

Apr. 01, 2019

Oct. 01, 2018

Jun. 30, 2020

Mar. 31, 2020

Dec. 31, 2019

Sep. 30, 2019

Jun. 30, 2019

Dec. 31, 2018

Jun. 30, 2020

Jun. 30, 2019

Business Acquisition, Contingent Consideration [Line Items]

Payments to Acquire Businesses, Gross

$ 17,100,000

$ (20,600,000)

$ (175,800,000)

Goodwill

$ 1,816,900,000

$ 1,800,900,000

1,816,900,000

Prepaid Royalties

$ 22,000,000

Special charges

9,500,000

$ 6,200,000

26,100,000

17,700,000

Gain (Loss) on Disposition of Other Assets

3.9

$ 15,900,000

4.2

Business Exit Costs

$ 4

BreatheAcquisition [Member]

Business Acquisition, Contingent Consideration [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables

$ 300,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory

6,300,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other

100,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment

2,100,000

Goodwill

60,200,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets

200,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable

(500,000)

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other

(1,600,000)

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities

(800,000)

Payments to Acquire Businesses, Net of Cash Acquired

127,600,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities

900,000

Voalte [Member]

Business Acquisition, Contingent Consideration [Line Items]

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

$ 8.4

8.4

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

$ 15,000,000

Payments to Acquire Businesses, Gross

175,800,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables

5,800,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory

100,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other

2,700,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment

200,000

Goodwill

98,500,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable

(1,700,000)

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue

(10,700,000)

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other

(4,300,000)

Business Combination, Contingent Consideration, Liability

5,200,000

Payments to Acquire Businesses, Net of Cash Acquired

181,000,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities

(9,800,000)

Excel [Member]

Business Acquisition, Contingent Consideration [Line Items]

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

$ 1,600,000

500,000

700,000

Contingent Consideration Classified as Equity, Fair Value Disclosure

4,500,000

Business Combination, Integration Related Costs

600,000

1.4

Excel Medical

Business Acquisition, Contingent Consideration [Line Items]

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

15,000,000

Payments to Acquire Businesses, Gross

13,100,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables

600,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory

900,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other

100,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment

100,000

Goodwill

9,800,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other

(2,700,000)

Business Combination, Contingent Consideration, Liability

6,100,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities

(500,000)

Payments to Acquire Businesses, Net of Cash Acquired

19,200,000

Breathe [Member]

Business Acquisition, Contingent Consideration [Line Items]

Business Combination, Integration Related Costs

0.5

2

Special charges

$ 0.4

$ 2.7

Connecta [Member]

Business Acquisition, Contingent Consideration [Line Items]

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

$ 4,000,000

Payments to Acquire Businesses, Gross

7,500,000

Goodwill

4,800,000

Business Combination, Contingent Consideration, Liability

200,000

Payments to Acquire Businesses, Net of Cash Acquired

7,700,000

Business Combination, Integration Related Costs

$ 300,000

Business Combination, Contingent Consideration Arrangements, milestone achievement, years

3 years 6 months

Noncompete Agreements [Member] | Voalte [Member]

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

2,700,000

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

5 years

Trade Names [Member] | BreatheAcquisition [Member]

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

4,000,000

Trade Names [Member] | Voalte [Member]

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

13,500,000

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

10 years

Trade Names [Member] | Breathe [Member]

Business Acquisition, Contingent Consideration [Line Items]

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

2 years

Customer Relationships [Member] | Voalte [Member]

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

29,000,000

Customer Relationships [Member] | Breathe [Member]

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

400,000

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

8 years

Developed Technology Rights [Member] | BreatheAcquisition [Member]

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

$ 56,000,000

Developed Technology Rights [Member] | Voalte [Member]

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

$ 55,000,000

Developed Technology Rights [Member] | Excel Medical

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

$ 10,900,000

Developed Technology Rights [Member] | Connecta [Member]

Business Acquisition, Contingent Consideration [Line Items]

Intangible Assets

$ 2,900,000

Technology-Based Intangible Assets [Member] | Voalte [Member]

Business Acquisition, Contingent Consideration [Line Items]

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

8 years

Technology-Based Intangible Assets [Member] | Excel [Member]

Business Acquisition, Contingent Consideration [Line Items]

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

5 years

Technology-Based Intangible Assets [Member] | Breathe [Member]

Business Acquisition, Contingent Consideration [Line Items]

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

11 years

Technology-Based Intangible Assets [Member] | Connecta [Member]

Business Acquisition, Contingent Consideration [Line Items]

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

10 years

Customer-Related Intangible Assets | Voalte [Member]

Business Acquisition, Contingent Consideration [Line Items]

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

10 years

Videomed [Member] | Videomed [Member]

Business Acquisition, Contingent Consideration [Line Items]

Payments to Acquire Businesses, Gross

$ 9,400,000

Business Combination, Contingent Consideration, Liability

$ 3,700,000

Business Combinations Dispositi

Business Combinations Dispositions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Sep. 30, 2019	Jun. 30, 2020
Noncash or Part Noncash Divestitures [Line Items]
Gain (Loss) on Disposition of Other Assets	$ 3.9	$ 15,900,000	$ 4.2

Business Combinations Breathe A

Business Combinations Breathe Acquisition (Details) - USD ($)	Oct. 01, 2018	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019	Sep. 03, 2019
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 17,100,000	$ (20,600,000)	$ (175,800,000)
Goodwill		$ 1,816,900,000		$ 1,800,900,000
Customer Relationships [Member] | Breathe [Member]
Business Acquisition [Line Items]
Intangible Assets					$ 400,000

Goodwill (Schedule of Goodwill

Goodwill (Schedule of Goodwill Activity) (Details) - USD ($) $ in Millions	Jun. 30, 2020	Sep. 30, 2019	Apr. 01, 2019
Goodwill [Roll Forward]
Goodwill, net	$ 1,816.9	$ 1,800.9
Voalte [Member]
Goodwill [Roll Forward]
Goodwill, net			$ 98.5

Financing Agreements (Schedule

Financing Agreements (Schedule of Total Debt) (Details) - USD ($)	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	May 01, 2020	Sep. 30, 2019
Debt Instrument [Line Items]
Repayments of Long-term Debt	$ (37,600,000)	$ 100,000
Long-term Debt, by Current and Noncurrent [Abstract]
Revolving credit facility, matures September 2021	250,100,000			$ 660,400,000
Total Long-term debt	1,782,600,000			1,783,100,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Letters of Credit Outstanding, Amount	7,200,000			7.2
Long-term Debt, by Current and Noncurrent [Abstract]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,077,800,000
Line of Credit Facility, Remaining Borrowing Capacity				$ 1,112,800,000
Senior Unsecured 5.75% Notes due on September 1, 2023 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate	5.75%
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate				5.00%
Securitization Program [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Debt Instrument, Face Amount			$ 110,000,000
Note Securitization Facility [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Debt Instrument, Face Amount			$ 90,000,000

Financing Agreements (Future Pr

Financing Agreements (Future Principal Payments of Long-Term Debt) (Details) $ in Millions	Sep. 30, 2019USD ($)
Senior Unsecured 4.375% Notes due September 2027 [Member]
Debt Instrument [Line Items]
Debt Issuance Costs, Gross	$ 6.3

Financing Agreements (Narrative

Financing Agreements (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended		13 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	May 31, 2021	May 01, 2020	Sep. 30, 2019
Debt Instrument [Line Items]
Payment of long-term debt			$ (37,600,000)	$ 100,000
Payment for Debt Extinguishment or Debt Prepayment Cost			(12,200,000)	0
Gain (Loss) on Extinguishment of Debt	$ 0	$ 0	(15,600,000)	$ 0
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolving credit facility, matures September 2021							$ 80,000,000
Securitization Program [Member]
Debt Instrument [Line Items]
Debt Instrument, Term					364 days
Aggregate value of debt						$ 110,000,000
Note Securitization Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Term					364 days
Aggregate value of debt						$ 90,000,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Senior revolving credit facility, maximum borrowing amount	1,077,800,000		1,077,800,000
Current borrowing capacity under the facility							1,112,800,000
Outstanding letters of credit	7,200,000		7,200,000				$ 7.2
Debtor-in-Possession Financing, Borrowings Outstanding	$ 115,000,000		$ 115,000,000
Senior Unsecured 5.75% Notes due on September 1, 2023 [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate	5.75%		5.75%
Payment for Debt Extinguishment or Debt Prepayment Cost	$ (12,200,000)
Gain (Loss) on Extinguishment of Debt	15,600,000
Write off of Deferred Debt Issuance Cost	$ 3,400,000
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate							5.00%
Senior Unsecured 4.375% Notes due September 2027 [Member]
Debt Instrument [Line Items]
Aggregate value of debt							$ 425,000,000
Unsecured debenture interest rate							4.375%
London Interbank Offered Rate (LIBOR) [Member] | Securitization Program [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate	0.80%		0.80%
London Interbank Offered Rate (LIBOR) [Member] | Note Securitization Facility [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate	0.90%		0.90%

Financing Agreements (Schedul_2

Financing Agreements (Schedule of Fair Value) (Details) - USD ($) $ in Millions	Jun. 30, 2020	Sep. 30, 2019
Debt Instrument [Line Items]
Total	$ 792.9	$ 795.9
Unsecured Debentures [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	$ 47	48.1
Senior Unsecured 5.75% Notes due on September 1, 2023 [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate	5.75%
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	$ 310.5	$ 312.4
Unsecured debenture interest rate		5.00%
Senior Unsecured 4.375% Notes due September 2027 [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	$ 435.4	$ 435.4
Unsecured debenture interest rate		4.375%

Derivatives (Details)

Derivatives (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	$ (30,400,000)		$ (30,400,000)		$ 10,300,000
Cash Flow Hedging [Member] | Other Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net					900,000
Cash Flow Hedging [Member] | Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	(49,800,000)		(49,800,000)		(7,700,000)
Currency Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	13,600,000		13,600,000		6,700,000
Currency Swap [Member] | Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	(700,000)		(700,000)
Currency Swap [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net					200,000
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	155,400,000		155,400,000		76,700,000
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	500,000	$ 500,000	500,000
Derivative, Gain on Derivative	(100,000)		1,100,000
Derivative, Loss on Derivative		(1,300,000)		$ (1,600,000)
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	750,000,000		750,000,000		750,000,000
Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	198,300,000		198,300,000
Net Investment Hedging [Member] | Other Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	20,100,000		20,100,000		$ 16,900,000
Net Investment Hedging [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	$ 1,300,000	$ 1.3	$ 3,900,000	$ 3.9

Leases (Details)

Leases (Details) - USD ($)	3 Months Ended		9 Months Ended			12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2017	Sep. 30, 2019	Sep. 30, 2018
Leases [Abstract]
Lease, Cost	$ 9,900,000		$ 29,300,000
Operating Lease, Expense	6,800,000		20,600,000
Variable Lease, Cost	3,100,000		8,700,000
Operating Lease, Right-of-Use Asset	75,300,000		75,300,000
Operating Lease, Liability, Current	23,100,000		23,100,000
Operating Lease, Liability, Noncurrent	$ 56,800,000		$ 56,800,000
Lessee, Operating Lease, Discount Rate	3.30%		3.30%
Operating Lease, Weighted Average Remaining Lease Term	4 years 7 months 6 days		4 years 7 months 6 days
Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year	$ 6,800,000		$ 6,800,000
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months	24,000,000		24,000,000
Lessee, Operating Lease, Liability, Payments, Due Year Two	18,700,000		18,700,000
Lessee, Operating Lease, Liability, Payments, Due Year Three	13,400,000		13,400,000
Lessee, Operating Lease, Liability, Payments, Due Year Four	8,300,000		8,300,000
Lessee, Operating Lease, Liability, Payments, Due Year Five	5,100,000		5,100,000
Lessee, Operating Lease, Liability, Payments, Due after Year Five	10,100,000		10,100,000
Lessee, Operating Lease, Liability, Payments, Due	86,400,000		86,400,000
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(6,500,000)		(6,500,000)
Operating Lease, Liability	79,900,000		79,900,000
Operating Leases, Future Minimum Payments Receivable						$ 94,900,000
Operating Leases, Future Minimum Payments Receivable, Current						25,700,000
Operating Leases, Future Minimum Payments Receivable, in Two Years						21,400,000
Operating Leases, Future Minimum Payments Receivable, in Three Years						15,700,000
Operating Leases, Future Minimum Payments Receivable, in Four Years						11,100,000
Operating Leases, Future Minimum Payments Receivable, in Five Years						6,400,000
Operating Leases, Future Minimum Payments Receivable, Thereafter						14,600,000
Operating Leases, Rent Expense					$ 38,000,000	$ 39,800,000	$ 41,300,000
Rental expenses	35,400,000	$ 37,900,000	110,900,000	$ 114,000,000
Lessee, Lease, Description [Line Items]
Operating Lease, Expense	6,800,000		20,600,000
Variable Lease, Cost	$ 3,100,000		$ 8,700,000
Operating Lease, Weighted Average Remaining Lease Term	4 years 7 months 6 days		4 years 7 months 6 days
Lease, Cost	$ 9,900,000		$ 29,300,000
Lessee, Operating Leases [Text Block]			Leases Hillrom as the Lessee We determine if an arrangement is a lease or contains a lease at contract inception. We lease real estate, automobiles, and equipment under various operating leases. A lease liability and ROU asset is recognized for operating leases with terms greater than one year at the lease commencement date. The lease liability is measured as the present value of all remaining fixed payments calculated using our estimated secured incremental borrowing rate. The ROU asset is measured as the sum of the lease liability and any initial indirect costs incurred, less any lease incentives received. We use our estimated secured incremental borrowing rate as most lease agreements do not specify an interest rate. Our lease agreements include leases that have both lease and non-lease components. We have elected to account for lease components and the associated non-lease components as a single lease component. Our leases have remaining lease terms of approximately 1 year to 8 years. Many of our real estate and equipment leases include options to renew. Renewal periods are generally not included when calculating the remaining lease term unless we are reasonably certain to exercise a renewal option based on beneficial terms or significance of the leased asset to our operations. Expense for operating leases and leases with a term of one year or less is recognized on a straight-line basis over the lease term. Lease expense is recorded in Cost of goods sold or Selling and administrative expenses based on the purpose of the leased asset. The following table summarizes our lease expense. Three Months Ended June 30, 2020 Nine Months Ended June 30, 2020 Operating lease expense $ 6.8 $ 20.6 Short-term leases and variable lease payments 3.1 8.7 Total $ 9.9 $ 29.3 The following table summarizes the balance sheet classification of our operating leases and amounts of the ROU asset and lease liability as of June 30, 2020: Balance Sheet Classification June 30, 2020 Right-of-use assets Other assets $ 75.3 Current lease liabilities Other current liabilities 23.1 Non-current lease liabilities Other long-term liabilities 56.8 Supplemental information: June 30, 2020 Weighted-average discount rate 3.3 % Weighted-average remaining lease term in years 4.6 The following table summarizes the maturities of our operating leases as of June 30, 2020: Fiscal Year Amount Remaining 2020 $ 6.8 2021 24.0 2022 18.7 2023 13.4 2024 8.3 2025 5.1 Thereafter 10.1 Total lease payments 86.4 Less: imputed interest (6.5) Total lease liability $ 79.9 Disclosures Related to Periods Prior to Adopting the New Lease Guidance As disclosed in the 2019 Form 10-K, future minimum payments under non-cancellable operating leases (excluding executory costs) aggregating $94.9 million for manufacturing facilities, warehouse distribution centers, service centers, sales offices, automobiles, and other equipment consisted of the following: Fiscal Year Amount 2020 $ 25.7 2021 21.4 2022 15.7 2023 11.1 2024 6.4 2025 and beyond 14.6 Rental expense in fiscal 2019, 2018 and 2017 was $39.8 million, $41.3 million and $38.0 million. Hillrom as the Lessor
Maximum [Member]
Lessee, Lease, Description [Line Items]
Lessor, Operating Lease, Term of Contract	8 years		8 years
Minimum [Member]
Lessee, Lease, Description [Line Items]
Lessor, Operating Lease, Term of Contract	1 year		1 year

Retirement and Postretirement_3

Retirement and Postretirement Plans (Defined Benefit Plans) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 1,900,000	$ 3,100,000	$ 6,800,000	$ 9,400,000
Expected return on plan assets	(3,400,000)	(3,700,000)	(10,800,000)	(11,100,000)
Defined Benefit Plan, Amortization of Prior Service Cost (Credit)	0	100,000	100,000	100,000
Amortization of net loss	1,900,000	700,000	5,000,000	1,800,000
Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Remeasurement due to Settlement	(100,000)		8,400,000
Net pension expense	1,700,000	1,300,000	13,300,000	3,500,000
Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan	40,600,000
Defined contribution savings plans expense	7,300,000	6,900,000	23,600,000	21,400,000
Cost of Goods and Service Benchmark [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	500,000	500,000	1,300,000	1,200,000
Selling, General and Administrative Expenses [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 900,000	$ 600,000	$ 2,500,000	$ 2,100,000

Retirement and Postretirement_4

Retirement and Postretirement Plans (Defined Contribution Plans) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Retirement Benefits [Abstract]
Defined contribution savings plans expense	$ 7.3	$ 6.9	$ 23.6	$ 21.4

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) (Schedule of Changes in AOCL by Component) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 7,700,000
Other comprehensive income (loss)
Total Other Comprehensive Income (Loss), net of tax	11,400,000	$ (4,900,000)	$ (29,700,000)	$ (26,800,000)
Accumulated other comprehensive loss
Beginning balance			1,573,300,000
Net activity	11,400,000	(4,900,000)	(29,700,000)	(26,800,000)
Ending balance	1,652,400,000		1,652,400,000
Income tax expense	26,300,000	13,100,000	39,000,000	31,700,000
Net Income (Loss) Attributable to Parent	93,900,000	32,600,000	180,600,000	124,300,000
Available-for-sale Securities and Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				(800,000)
Other comprehensive income (loss)
Prior to reclassification	(6,000,000)	(10,800,000)	(39,700,000)	(14,200,000)
Reclassification from	(2,900,000)	(1,400,000)	(2,400,000)	(5,400,000)
Pre-tax	(8,900,000)	(12,200,000)	(42,100,000)	(19,600,000)
Tax effect	2,200,000	2,800,000	9,700,000	4,600,000
Total Other Comprehensive Income (Loss), net of tax	(6,700,000)	(9,400,000)	(32,400,000)	(15,000,000)
Accumulated other comprehensive loss
Beginning balance	(18,500,000)	12,000,000	7,200,000	16,800,000
Net activity	(6,700,000)	(9,400,000)	(32,400,000)	(15,000,000)
Ending balance	(25,200,000)	2,600,000	(25,200,000)	2,600,000
Net Income (Loss) Attributable to Parent	2,100,000	1,200,000	1,800,000	4,100,000
Foreign Currency Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				0
Other comprehensive income (loss)
Prior to reclassification	17,100,000	4,100,000	8,600,000	(13,100,000)
Reclassification from	0	0	0	0
Pre-tax	17,100,000	4,100,000	8,600,000	(13,100,000)
Tax effect	0	0	0	0
Total Other Comprehensive Income (Loss), net of tax	17,100,000	4,100,000	8,600,000	(13,100,000)
Accumulated other comprehensive loss
Beginning balance	(153,900,000)	(122,500,000)	(145,400,000)	(105,300,000)
Net activity	17,100,000	4,100,000	8,600,000	(13,100,000)
Ending balance	(136,800,000)	(118,400,000)	(136,800,000)	(118,400,000)
Change in Pension and Postretirement Defined Benefit Plans [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				6,200,000
Other comprehensive income (loss)
Prior to reclassification	200,000	0	100,000	100,000
Reclassification from	1,400,000	700,000	(7,700,000)	1,800,000
Pre-tax	1,600,000	700,000	(7,600,000)	1,900,000
Tax effect	600,000	300,000	(1,700,000)	600,000
Total Other Comprehensive Income (Loss), net of tax	1,000,000	400,000	(5,900,000)	1,300,000
Accumulated other comprehensive loss
Beginning balance	(51,200,000)	(29,800,000)	(44,300,000)	(24,500,000)
Net activity	1,000,000	400,000	(5,900,000)	1,300,000
Ending balance	(50,200,000)	(29,400,000)	(50,200,000)	(29,400,000)
Income tax expense	(600,000)	(300,000)	1,700,000	(6,800,000)
Change in Pension and Postretirement Defined Benefit Plans [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated other comprehensive loss
Net Income (Loss) Attributable to Parent	(800,000)	(400,000)	6,000,000	5,000,000
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				(5,400,000)
Other comprehensive income (loss)
Prior to reclassification	11,300,000	(6,700,000)	(31,000,000)	(27,200,000)
Reclassification from	(1,500,000)	(700,000)	(10,100,000)	(3,600,000)
Pre-tax	9,800,000	(7,400,000)	(41,100,000)	(30,800,000)
Tax effect	1,600,000	2,500,000	(11,400,000)	(4,000,000)
Total Other Comprehensive Income (Loss), net of tax	11,400,000	(4,900,000)	(29,700,000)	(26,800,000)
Accumulated other comprehensive loss
Beginning balance	(223,600,000)	(140,300,000)	(182,500,000)	(113,000,000)
Net activity	11,400,000	(4,900,000)	(29,700,000)	(26,800,000)
Ending balance	(212,200,000)	(145,200,000)	(212,200,000)	(145,200,000)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Other comprehensive income (loss)
Reclassification from	2,900,000	1,400,000	2,400,000	5,400,000
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated other comprehensive loss
Income tax expense	800,000	200,000	600,000	1,300,000
Foreign Exchange Forward [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Pre-tax	(800,000)	(400,000)	(1,000,000)	(100,000)
Total Other Comprehensive Income (Loss), net of tax	(600,000)	(300,000)	(800,000)	(100,000)
Accumulated other comprehensive loss
Beginning balance	0	400,000	200,000	200,000
Net activity	(600,000)	(300,000)	(800,000)	(100,000)
Ending balance	(600,000)	100,000	(600,000)	100,000
Foreign Exchange Forward [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Other comprehensive income (loss)
Tax effect	(200,000)	(100,000)	(200,000)	0
Interest Rate Swap [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Pre-tax	(4,600,000)	(10,800,000)	(43,000,000)	(28,800,000)
Total Other Comprehensive Income (Loss), net of tax	(3,500,000)	(8,300,000)	(33,100,000)	(22,100,000)
Accumulated other comprehensive loss
Beginning balance	(34,800,000)	5,300,000	(5,200,000)	18,300,000
Net activity	(3,500,000)	(8,300,000)	(33,100,000)	(22,100,000)
Ending balance	(38,300,000)	(3,000,000)	(38,300,000)	(3,000,000)
Interest Rate Swap [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				800,000
Other comprehensive income (loss)
Prior to reclassification	(2,900,000)	(9,000,000)	(41,700,000)	(23,200,000)
Reclassification from	1,700,000	1,800,000	1,300,000	5,600,000
Tax effect	(1,100,000)	(2,500,000)	(9,900,000)	(6,700,000)
Accumulated other comprehensive loss
Income tax expense	400,000	200,000	300,000	1,300,000
Net Income (Loss) Attributable to Parent	(1,300,000)	(1,600,000)	(1,000,000)	(4,300,000)
Currency Swap [Member] | Available-for-sale Securities and Hedges [Member]
Accumulated other comprehensive loss
Beginning balance	16,300,000	6,300,000	12,200,000	(1,700,000)
Currency Swap [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				0
Other comprehensive income (loss)
Prior to reclassification	(3,500,000)	(1,000,000)	1,900,000	9,300,000
Reclassification from	0	0	0	0
Tax effect	(900,000)	(200,000)	400,000	2,100,000
Foreign Exchange Contract [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Pre-tax	(3,500,000)	(1,000,000)	1,900,000	9,300,000
Total Other Comprehensive Income (Loss), net of tax	(2,600,000)	(800,000)	1,500,000	7,200,000
Accumulated other comprehensive loss
Net activity	(2,600,000)	(800,000)	1,500,000	7,200,000
Ending balance	13,700,000	5,500,000	13,700,000	5,500,000
Foreign Exchange | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification				0
Other comprehensive income (loss)
Prior to reclassification	400,000	(800,000)	100,000	(300,000)
Reclassification from	1,200,000	(400,000)	1,100,000	(200,000)
Accumulated other comprehensive loss
Income tax expense	400,000	0	300,000	0
Net Income (Loss) Attributable to Parent	$ (800,000)	$ 400,000	$ (800,000)	$ 200,000

Other Comprehensive Income (L_4

Other Comprehensive Income (Loss) (Schedule of Items Reclassified out of AOCL) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount reclassified	$ (120,200,000)	$ (45,700,000)	$ (219,600,000)	$ (156,000,000)
Tax effect	26,300,000	13,100,000	39,000,000	31,700,000
Net of tax	(93,900,000)	(32,600,000)	(180,600,000)	(124,300,000)
Net activity	11,400,000	(4,900,000)	(29,700,000)	(26,800,000)
Stockholders' Equity Attributable to Parent	1,652,400,000		1,652,400,000			$ 1,573,300,000
Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(2,900,000)	(1,400,000)	(2,400,000)	(5,400,000)
Net of tax	(2,100,000)	(1,200,000)	(1,800,000)	(4,100,000)
Prior to reclassification	(6,000,000)	(10,800,000)	(39,700,000)	(14,200,000)
Other Comprehensive Income (Loss), before Tax	(8,900,000)	(12,200,000)	(42,100,000)	(19,600,000)
Other Comprehensive Income (Loss), Tax	(2,200,000)	(2,800,000)	(9,700,000)	(4,600,000)
Net activity	(6,700,000)	(9,400,000)	(32,400,000)	(15,000,000)
Stockholders' Equity Attributable to Parent	(25,200,000)	2,600,000	(25,200,000)	2,600,000	$ (18,500,000)	7,200,000	$ 12,000,000	$ 16,800,000
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0	0	0
Prior to reclassification	17,100,000	4,100,000	8,600,000	(13,100,000)
Other Comprehensive Income (Loss), before Tax	17,100,000	4,100,000	8,600,000	(13,100,000)
Other Comprehensive Income (Loss), Tax	0	0	0	0
Net activity	17,100,000	4,100,000	8,600,000	(13,100,000)
Stockholders' Equity Attributable to Parent	(136,800,000)	(118,400,000)	(136,800,000)	(118,400,000)	(153,900,000)	(145,400,000)	(122,500,000)	(105,300,000)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	1,400,000	700,000	(7,700,000)	1,800,000
Tax effect	(600,000)	(300,000)	1,700,000	(6,800,000)
Prior to reclassification	200,000	0	100,000	100,000
Other Comprehensive Income (Loss), before Tax	1,600,000	700,000	(7,600,000)	1,900,000
Other Comprehensive Income (Loss), Tax	(600,000)	(300,000)	1,700,000	(600,000)
Net activity	1,000,000	400,000	(5,900,000)	1,300,000
Stockholders' Equity Attributable to Parent	(50,200,000)	(29,400,000)	(50,200,000)	(29,400,000)	(51,200,000)	(44,300,000)	(29,800,000)	(24,500,000)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	2,900,000	1,400,000	2,400,000	5,400,000
Accumulated Other Comprehensive Income (Loss) [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(1,500,000)	(700,000)	(10,100,000)	(3,600,000)
Prior to reclassification	11,300,000	(6,700,000)	(31,000,000)	(27,200,000)
Other Comprehensive Income (Loss), before Tax	9,800,000	(7,400,000)	(41,100,000)	(30,800,000)
Other Comprehensive Income (Loss), Tax	(1,600,000)	(2,500,000)	11,400,000	4,000,000
Net activity	11,400,000	(4,900,000)	(29,700,000)	(26,800,000)
Stockholders' Equity Attributable to Parent	(212,200,000)	(145,200,000)	(212,200,000)	(145,200,000)	(223,600,000)	(182,500,000)	(140,300,000)	(113,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net of tax	800,000	400,000	(6,000,000)	(5,000,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Tax effect	800,000	200,000	600,000	1,300,000
Foreign Exchange Forward [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Tax	(800,000)	(400,000)	(1,000,000)	(100,000)
Net activity	(600,000)	(300,000)	(800,000)	(100,000)
Stockholders' Equity Attributable to Parent	(600,000)	100,000	(600,000)	100,000	0	200,000	400,000	200,000
Foreign Exchange Forward [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), Tax	200,000	100,000	200,000	0
Interest Rate Swap [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Tax	(4,600,000)	(10,800,000)	(43,000,000)	(28,800,000)
Net activity	(3,500,000)	(8,300,000)	(33,100,000)	(22,100,000)
Stockholders' Equity Attributable to Parent	(38,300,000)	(3,000,000)	(38,300,000)	(3,000,000)	(34,800,000)	(5,200,000)	5,300,000	18,300,000
Interest Rate Swap [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	1,700,000	1,800,000	1,300,000	5,600,000
Tax effect	400,000	200,000	300,000	1,300,000
Net of tax	1,300,000	1,600,000	1,000,000	4,300,000
Prior to reclassification	(2,900,000)	(9,000,000)	(41,700,000)	(23,200,000)
Other Comprehensive Income (Loss), Tax	1,100,000	2,500,000	9,900,000	6,700,000
Foreign Exchange | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	1,200,000	(400,000)	1,100,000	(200,000)
Tax effect	400,000	0	300,000	0
Net of tax	800,000	(400,000)	800,000	(200,000)
Prior to reclassification	400,000	(800,000)	100,000	(300,000)
Currency Swap [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Stockholders' Equity Attributable to Parent					$ 16,300,000	$ 12,200,000	$ 6,300,000	$ (1,700,000)
Currency Swap [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0	0	0
Prior to reclassification	(3,500,000)	(1,000,000)	1,900,000	9,300,000
Other Comprehensive Income (Loss), Tax	900,000	200,000	(400,000)	(2,100,000)
Foreign Exchange Contract [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Tax	(3,500,000)	(1,000,000)	1,900,000	9,300,000
Net activity	(2,600,000)	(800,000)	1,500,000	7,200,000
Stockholders' Equity Attributable to Parent	$ 13,700,000	$ 5,500,000	$ 13,700,000	$ 5,500,000

Special Charges (Narrative) (De

Special Charges (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restructuring Cost and Reserve [Line Items]
Special charges	$ 9,500,000	$ 6,200,000	$ 26,100,000	$ 17,700,000
Restructuring charges			4,900,000
Site Consolidation [Member] | Facility Closing [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	400,000	1,500,000	1,600,000	6,500,000
Business Optimization [Member]
Restructuring Cost and Reserve [Line Items]
Special charges		$ 4,700,000		$ 11,200,000
Business Optimization [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	2,400,000		9,200,000
Global Restructuring Program [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	6,700,000		15,300,000
Restructuring charges	9,000,000		28,300,000
Property, Plant and Equipment [Member] | Global Restructuring Program [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 2,300,000		$ 13,000,000

Special Charges (Schedule of Re

Special Charges (Schedule of Restructuring Activity) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restructuring Cost and Reserve [Line Items]
Beginning Balance			$ 8,500,000
Expenses			4,900,000
Cash payments			(9,600,000)
Restructuring Reserve, Accrual Adjustment			(500,000)
Ending Balance	$ 3,300,000		3,300,000
Special charges	9,500,000	$ 6,200,000	26,100,000	$ 17,700,000
Business Optimization [Member]
Restructuring Cost and Reserve [Line Items]
Special charges		$ 4,700,000		$ 11,200,000
Other Restructuring [Member] | Global Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Expenses	9,000,000		28,300,000
Special charges	6,700,000		15,300,000
Employee Severance [Member] | Business Optimization [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	$ 2,400,000		$ 9,200,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended			9 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Effective tax rate	21.90%		28.70%	17.80%	20.30%
Income tax expense	$ 26,300,000		$ 13,100,000	$ 39,000,000	$ 31,700,000
Tax Adjustments, Settlements, and Unusual Provisions	$ 4.1
Voalte [Member]
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability		$ 8.4		$ 8.4

Earnings per Common Share (Deta

Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Earnings Per Share [Abstract]
Net Income (Loss) Attributable to Parent	$ 93.9	$ 32.6	$ 180.6	$ 124.3
Net income attributable to common shareholders per common share - Basic (usd per share)	$ 1.41	$ 0.49	$ 2.71	$ 1.86
Net income attributable to common shareholders per common share - Diluted (usd per share)	$ 1.40	$ 0.48	$ 2.68	$ 1.84
Average Common Shares Outstanding - Basic (in shares)	66,558	66,777	66,660	66,822
Add potential effect of exercise of stock options and other unvested equity awards (in shares)	625	669	632	662
Average shares outstanding - Diluted (in shares)	67,183	67,446	67,292	67,484
Shares with anti-dilutive effect excluded from the computation of Diluted EPS (in shares)	291	258	298	299

Common Stock (Details)

Common Stock (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Class of Stock Disclosures [Abstract]
Share-based Payment Arrangement, Noncash Expense	$ 27.2	$ 26.9

Common Stock Common Stock (Shar

Common Stock Common Stock (Share Repurchase Program) (Details) - USD ($)	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Equity, Class of Treasury Stock [Line Items]
Payments for Repurchase of Common Stock	$ 54,100,000	$ (75,000,000)
Payments for Repurchase of Common Stock	$ 54,100,000	$ 75,000,000

Common Stock Common Stock (Narr

Common Stock Common Stock (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payment, Tax Withholding, Share-based Payment Arrangement	$ 600,000	$ (200,000)	$ (16,400,000)	$ (4,200,000)
Payments for Repurchase of Common Stock			$ 54,100,000	$ (75,000,000)

Guarantees (Details)

Guarantees (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2020
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at beginning of period	$ 29	$ 29.7
Provision for warranties in the period	5.2	13
Warranty claims in the period	(3.7)	(12.2)
Balance at end of period	$ 30.5	$ 30.5

Segment Reporting (Details)

Segment Reporting (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Segment Reporting Information [Line Items]
Revenues	$ 767,500,000	$ 726,800,000	$ 2,175,700,000	$ 2,124,500,000
Special charges	9,500,000	6,200,000	26,100,000	17,700,000
Operating profit	135,300,000	69,900,000	301,500,000	222,000,000
Interest expense	(17,300,000)	(23,100,000)	(55,800,000)	(66,200,000)
Gain (Loss) on Extinguishment of Debt	0	0	(15,600,000)	0
Investment income (expense) and other, net	2,200,000	(1,100,000)	(10,500,000)	200,000
Income Before Income Taxes	120,200,000	45,700,000	219,600,000	156,000,000
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Non-allocated operating costs, administrative and other	70,200,000	94,700,000	198,300,000	218,400,000
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	767,500,000	726,800,000	2,175,700,000	2,124,500,000
Operating Segments [Member] | Patient Support Systems [Member]
Segment Reporting Information [Line Items]
Revenues	447,800,000	374,500,000	1,174,000,000	1,075,100,000
Divisional Income	129,200,000	83,500,000	262,400,000	215,400,000
Operating Segments [Member] | Front Line Care [Member]
Segment Reporting Information [Line Items]
Revenues	252,100,000	244,400,000	765,000,000	720,900,000
Divisional Income	81,100,000	69,500,000	232,500,000	198,500,000
Operating Segments [Member] | Surgical Solutions [Member]
Segment Reporting Information [Line Items]
Revenues	67,600,000	107,900,000	236,700,000	328,500,000
Divisional Income	4,700,000	17,800,000	31,000,000	44,200,000
Geographic Distribution, Domestic [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	507,200,000	529,400,000	1,495,600,000	1,490,900,000
Geographic Distribution, Domestic [Member] | Operating Segments [Member] | Patient Support Systems [Member]
Segment Reporting Information [Line Items]
Revenues	316,900,000	290,800,000	872,800,000	806,100,000
Geographic Distribution, Domestic [Member] | Operating Segments [Member] | Front Line Care [Member]
Segment Reporting Information [Line Items]
Revenues	167,800,000	178,400,000	525,200,000	515,100,000
Geographic Distribution, Domestic [Member] | Operating Segments [Member] | Surgical Solutions [Member]
Segment Reporting Information [Line Items]
Revenues	22,500,000	60,200,000	97,600,000	169,700,000
Non-US [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	260,300,000	197,400,000	680,100,000	633,600,000
Non-US [Member] | Operating Segments [Member] | Patient Support Systems [Member]
Segment Reporting Information [Line Items]
Revenues	130,900,000	83,700,000	301,200,000	269,000,000
Non-US [Member] | Operating Segments [Member] | Front Line Care [Member]
Segment Reporting Information [Line Items]
Revenues	84,300,000	66,000,000	239,800,000	205,800,000
Non-US [Member] | Operating Segments [Member] | Surgical Solutions [Member]
Segment Reporting Information [Line Items]
Revenues	$ 45,100,000	$ 47,700,000	$ 139,100,000	$ 158,800,000

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Jun. 30, 2020USD ($)
Uninsured Risk [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Deductibles and self-insured retentions	$ 1

Uncategorized Items - hrc-20200

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 633,800,000